{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T14:23:55Z","timestamp":1790778235324,"version":"4.1.0"},"reference-count":482,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2022,4,24]],"date-time":"2022-04-24T00:00:00Z","timestamp":1650758400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Fragility fracture is a worldwide problem and a main cause of disability and impaired quality of life. It is primarily caused by osteoporosis, characterized by impaired bone quantity and or quality. Proper diagnosis of osteoporosis is essential for prevention of fragility fractures. Osteoporosis can be primary in postmenopausal women because of estrogen deficiency. Secondary forms of osteoporosis are not uncommon in both men and women. Most systemic illnesses and organ dysfunction can lead to osteoporosis. The kidney plays a crucial role in maintaining physiological bone homeostasis by controlling minerals, electrolytes, acid-base, vitamin D and parathyroid function. Chronic kidney disease with its uremic milieu disturbs this balance, leading to renal osteodystrophy. Diabetes mellitus represents the most common secondary cause of osteoporosis. Thyroid and parathyroid disorders can dysregulate the osteoblast\/osteoclast functions. Gastrointestinal disorders, malnutrition and malabsorption can result in mineral and vitamin D deficiencies and bone loss. Patients with chronic liver disease have a higher risk of fracture due to hepatic osteodystrophy. Proinflammatory cytokines in infectious, autoimmune, and hematological disorders can stimulate osteoclastogenesis, leading to osteoporosis. Moreover, drug-induced osteoporosis is not uncommon. In this review, we focus on causes, pathogenesis, and management of secondary osteoporosis.<\/jats:p>","DOI":"10.3390\/jcm11092382","type":"journal-article","created":{"date-parts":[[2022,4,24]],"date-time":"2022-04-24T22:22:41Z","timestamp":1650838961000},"page":"2382","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":143,"title":["Secondary Osteoporosis and Metabolic Bone Diseases"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2636-0966","authenticated-orcid":false,"given":"Mahmoud M.","family":"Sobh","sequence":"first","affiliation":[{"name":"Mansoura Nephrology and Dialysis Unit, Mansoura University, Mansoura 35516, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1157-9770","authenticated-orcid":false,"given":"Mohamed","family":"Abdalbary","sequence":"additional","affiliation":[{"name":"Mansoura Nephrology and Dialysis Unit, Mansoura University, Mansoura 35516, Egypt"},{"name":"Division of Nephrology, Bone and Mineral Metabolism, University of Kentucky, Lexington, KY 40506, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherouk","family":"Elnagar","sequence":"additional","affiliation":[{"name":"Mansoura Nephrology and Dialysis Unit, Mansoura University, Mansoura 35516, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman","family":"Nagy","sequence":"additional","affiliation":[{"name":"Mansoura Nephrology and Dialysis Unit, Mansoura University, Mansoura 35516, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nehal","family":"Elshabrawy","sequence":"additional","affiliation":[{"name":"Mansoura Nephrology and Dialysis Unit, Mansoura University, Mansoura 35516, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4682-2777","authenticated-orcid":false,"given":"Mostafa","family":"Abdelsalam","sequence":"additional","affiliation":[{"name":"Mansoura Nephrology and Dialysis Unit, Mansoura University, Mansoura 35516, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamyar","family":"Asadipooya","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, University of Kentucky, Lexington, KY 40506, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9072-5029","authenticated-orcid":false,"given":"Amr","family":"El-Husseini","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Bone and Mineral Metabolism, University of Kentucky, Lexington, KY 40506, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,4,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"4431","DOI":"10.1210\/jc.2002-020275","article-title":"Yield of Laboratory Testing to Identify Secondary Contributors to Osteoporosis in Otherwise Healthy Women","volume":"87","author":"Tannenbaum","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1007\/s00198-011-1713-z","article-title":"Interpretation and use of FRAX in clinical practice","volume":"22","author":"Kanis","year":"2011","journal-title":"Osteoporos. Int."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"538","DOI":"10.4103\/1319-2442.206439","article-title":"Prevalence of osteoporosis in patients with chronic kidney disease (stages 3\u20135) in comparison with age-and sex-matched controls: A study from Kashmir Valley Tertiary Care Center","volume":"28","author":"Najar","year":"2017","journal-title":"Saudi J. Kidney Dis. Transpl."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.3109\/0886022X.2013.815102","article-title":"Bone mineral density in patients with predialysis chronic kidney disease","volume":"35","author":"Aggarwal","year":"2013","journal-title":"Ren. Fail."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1136\/jim-2015-000043","article-title":"Bone mineral density and biochemical markers of bone metabolism in predialysis patients with chronic kidney disease","volume":"64","author":"Fidan","year":"2016","journal-title":"J. Investig. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"S116","DOI":"10.1016\/j.ekir.2021.03.290","article-title":"Pos-275 osteoporosis in ckd: Prevalence and associated factors in a guatemalan center","volume":"6","author":"Mazariegos","year":"2021","journal-title":"Kidney Int. Rep."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1159\/000515534","article-title":"Bone Quality in CKD Patients: Current Concepts and Future Directions\u2013Part I","volume":"7","author":"Asadipooya","year":"2021","journal-title":"Kidney Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1681\/ASN.2010121253","article-title":"Differences in bone quality in low- and high-turnover renal osteodystrophy","volume":"23","author":"Malluche","year":"2012","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"818","DOI":"10.7326\/M15-1361","article-title":"Treatment of Low Bone Density or Osteoporosis to Prevent Fractures in Men and Women: A Clinical Practice Guideline Update From the American College of Physicians","volume":"166","author":"Qaseem","year":"2017","journal-title":"Ann. Intern. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"564","DOI":"10.4158\/GL-2020-0524","article-title":"American association of clinical endocrinologists\/american college of endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis- 2020 update executive summary","volume":"26","author":"Camacho","year":"2020","journal-title":"Endocr. Pract."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1038\/sj.ki.5001754","article-title":"Incidence and risk factors for hip or other bone fractures among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study","volume":"70","author":"Jadoul","year":"2006","journal-title":"Kidney Int."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1111\/jgs.14237","article-title":"One-Year Mortality After Hip Fracture: Development and Validation of a Prognostic Index","volume":"64","author":"Cenzer","year":"2016","journal-title":"J. Am. Geriatr. Soc."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"18718","DOI":"10.1038\/s41598-019-55196-6","article-title":"One-year mortality after hip fracture surgery and prognostic factors: A prospective cohort study","volume":"9","author":"Morri","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1053\/ajkd.2000.19812","article-title":"Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormone","volume":"36","author":"Coco","year":"2000","journal-title":"Am. J. Kidney Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S0272-6386(04)00958-8","article-title":"Increased risk of mortality associated with hip fracture in the dialysis population","volume":"44","author":"Mittalhenkle","year":"2004","journal-title":"Am. J. Kidney Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1038\/sj.ki.5000414","article-title":"Definition, evaluation, and classification of renal osteodystrophy: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"69","author":"Moe","year":"2006","journal-title":"Kidney Int."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1681\/ASN.2008070783","article-title":"Initial FGF23-mediated signaling occurs in the distal convoluted tubule","volume":"20","author":"Farrow","year":"2009","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"G1036","DOI":"10.1152\/ajpgi.00243.2005","article-title":"1\u03b1, 25-Dihydroxyvitamin D3 upregulates FGF23 gene expression in bone: The final link in a renal-gastrointestinal-skeletal axis that controls phosphate transport","volume":"289","author":"Kolek","year":"2005","journal-title":"Am. J. Physiol.-Gastrointest. Liver Physiol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1006\/bbrc.2000.4226","article-title":"Severely reduced production of klotho in human chronic renal failure kidney","volume":"280","author":"Koh","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1359\/JBMR.0301264","article-title":"FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis","volume":"19","author":"Shimada","year":"2004","journal-title":"J. Bone Miner. Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"F1577","DOI":"10.1152\/ajprenal.00463.2006","article-title":"Fibroblast growth factor 23 impairs phosphorus and vitamin D metabolism in vivo and suppresses 25-hydroxyvitamin D-1\u03b1-hydroxylase expression in vitro","volume":"293","author":"Perwad","year":"2007","journal-title":"Am. J. Physiol.-Ren. Physiol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2337\/diaspect.21.1.19","article-title":"Secondary hyperparathyroidism and chronic kidney disease","volume":"21","author":"Tomasello","year":"2008","journal-title":"Diabetes Spectr."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1002\/jbmr.5650110714","article-title":"Direct effect of phosphorus on PTH secretion from whole rat parathyroid glands in vitro","volume":"11","author":"Almaden","year":"1996","journal-title":"J. Bone Miner. Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1046\/j.1523-1755.2001.00027.x","article-title":"Parathyroid hyperplasia in uremic rats precedes down-regulation of the calcium receptor","volume":"60","author":"Ritter","year":"2001","journal-title":"Kidney Int."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1172\/JCI116720","article-title":"Decreased 1, 25-dihydroxyvitamin D3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients","volume":"92","author":"Fukuda","year":"1993","journal-title":"J. Clin. Investig."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1093\/ndt\/gfz078","article-title":"Serum dickkopf-related protein 1 and sclerostin may predict the progression of chronic kidney disease in Japanese patients","volume":"34","author":"Taniguchi","year":"2019","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1093\/ckj\/sfab081","article-title":"Sclerostin and DKK1 circulating levels associate with low bone turnover in patients with chronic kidney disease Stages 3 and 4","volume":"14","author":"Neto","year":"2021","journal-title":"Clin. Kidney J."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s001090100226","article-title":"Role of receptor activator of nuclear factor-\u03baB ligand and osteoprotegerin in bone cell biology","volume":"79","author":"Hofbauer","year":"2001","journal-title":"J. Mol. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1053\/j.ackd.2006.10.010","article-title":"Bone Health in Chronic Kidney Disease\u2013Mineral and Bone Disease","volume":"14","author":"Sprague","year":"2007","journal-title":"Adv. Chronic Kidney Dis."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1093\/ndt\/14.8.1922","article-title":"Risk factors for reduced bone density in haemodialysis patients","volume":"14","author":"Taal","year":"1999","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/jbmr.3608","article-title":"Poor Vitamin K Status Is Associated with Low Bone Mineral Density and Increased Fracture Risk in End-Stage Renal Disease","volume":"34","author":"Evenepoel","year":"2019","journal-title":"J. Bone Miner. Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00198-018-4704-5","article-title":"European guidance for the diagnosis and management of osteoporosis in postmenopausal women","volume":"30","author":"Kanis","year":"2019","journal-title":"Osteoporos. Int."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1681\/ASN.2009121208","article-title":"Bone mass and microarchitecture in CKD patients with fracture","volume":"21","author":"Nickolas","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/PL00004180","article-title":"A combination of low doses of 17 beta-estradiol and norethisterone acetate prevents bone loss and normalizes bone turnover in postmenopausal women","volume":"11","author":"Delmas","year":"2000","journal-title":"Osteoporos. Int."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1053\/j.ajkd.2021.07.027","article-title":"Diagnostic Accuracy of Noninvasive Bone Turnover Markers in Renal Osteodystrophy","volume":"79","author":"Behets","year":"2022","journal-title":"Am. J. Kidney Dis."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1053\/j.ajkd.2015.06.023","article-title":"Diagnostic Accuracy of Bone Turnover Markers and Bone Histology in Patients with CKD Treated by Dialysis","volume":"67","author":"Sprague","year":"2016","journal-title":"Am. J. Kidney Dis."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1681\/ASN.2010121275","article-title":"Discriminants of prevalent fractures in chronic kidney disease","volume":"22","author":"Nickolas","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/ndt\/gfr317","article-title":"Diagnostic usefulness of bone mineral density and biochemical markers of bone turnover in predicting fracture in CKD stage 5D patients--a single-center cohort study","volume":"27","author":"Iimori","year":"2012","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Malluche, H.H., and Faugere, M.C. (1986). Atlas of Mineralized Bone Histology, Karger.","DOI":"10.1159\/isbn.978-3-318-04339-6"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"235","DOI":"10.5414\/CNP65235","article-title":"Renal osteodystrophy: What\u2019s in a name? Presentation of a clinically useful new model to interpret bone histologic findings","volume":"65","author":"Malluche","year":"2006","journal-title":"Clin. Nephrol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.kint.2015.12.004","article-title":"Changing bone patterns with progression of chronic kidney disease","volume":"89","author":"Massy","year":"2016","journal-title":"Kidney Int."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1159\/000515542","article-title":"Bone Quality in Chronic Kidney Disease Patients: Current Concepts and Future Directions\u2014Part II","volume":"7","author":"Asadipooya","year":"2021","journal-title":"Kidney Dis."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.kisu.2017.04.001","article-title":"KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease\u2013Mineral and Bone Disorder (CKD-MBD)","volume":"7","author":"Wheeler","year":"2017","journal-title":"Kidney Int. Suppl."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1007\/s00774-018-0977-1","article-title":"Efficacy and safety of once-monthly risedronate in osteoporosis subjects with mild-to-moderate chronic kidney disease: A post hoc subgroup analysis of a phase III trial in Japan","volume":"37","author":"Sugimoto","year":"2019","journal-title":"J. Bone Miner. Metab."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1002\/jbmr.4235","article-title":"Safety of Oral Bisphosphonates in Moderate-to-Severe Chronic Kidney Disease: A Binational Cohort Analysis","volume":"36","author":"Robinson","year":"2021","journal-title":"J. Bone Miner. Res."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.jocd.2015.05.070","article-title":"Atypical Femoral Fractures-Ongoing and History of Bone-Specific Therapy, Concomitant Diseases, Medications, and Survival","volume":"19","author":"Muschitz","year":"2016","journal-title":"J. Clin. Densitom."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s11657-021-00971-0","article-title":"Denosumab in chronic kidney disease: A narrative review of treatment efficacy and safety","volume":"16","author":"Gopaul","year":"2021","journal-title":"Arch. Osteoporos."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1002\/jbmr.3676","article-title":"Effects of Denosumab and Alendronate on Bone Health and Vascular Function in Hemodialysis Patients: A Randomized, Controlled Trial","volume":"34","author":"Iseri","year":"2019","journal-title":"J. Bone Miner. Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1159\/000316708","article-title":"Treatment of Hemodialysis-Associated Adynamic Bone Disease with Teriparatide (PTH1-34): A Pilot Study","volume":"33","author":"Cejka","year":"2010","journal-title":"Kidney Blood Press. Res."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1159\/000341864","article-title":"Impact of long-term cinacalcet, ibandronate or teriparatide therapy on bone mineral density of hemodialysis patients: A pilot study","volume":"36","author":"Mitsopoulos","year":"2012","journal-title":"Am. J. Nephrol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1007\/s00198-015-3377-6","article-title":"Once-weekly teriparatide in hemodialysis patients with hypoparathyroidism and low bone mass: A prospective study","volume":"27","author":"Sumida","year":"2016","journal-title":"Osteoporos. Int."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/1744-9987.12867","article-title":"Impact of Weekly Teriparatide on the Bone and Mineral Metabolism in Hemodialysis Patients With Relatively Low Serum Parathyroid Hormone: A Pilot Study","volume":"24","author":"Yamamoto","year":"2020","journal-title":"Ther. Apher. Dial."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1080\/03007995.2019.1656955","article-title":"Abaloparatide in patients with mild or moderate renal impairment: Results from the ACTIVE phase 3 trial","volume":"35","author":"Bilezikian","year":"2019","journal-title":"Curr. Med. Res. Opin."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1136\/annrheumdis-2020-eular.4539","article-title":"OP0297|Efficacy and safety of romosozumab among postmenopausal women with osteoporosis and mild-to-moderate chronic kidney disease","volume":"79","author":"Miller","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1007\/s00774-021-01253-y","article-title":"Efficacy of romosozumab in patients with osteoporosis on maintenance hemodialysis in Japan; An observational study","volume":"39","author":"Sato","year":"2021","journal-title":"J. Bone Miner. Metab."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"115457","DOI":"10.1016\/j.bone.2020.115457","article-title":"The risk of hip and non-vertebral fractures in type 1 and type 2 diabetes: A systematic review and meta-analysis update","volume":"137","author":"Vilaca","year":"2020","journal-title":"Bone"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1007\/s00198-021-06032-z","article-title":"Comparison of fracture risk between type 1 and type 2 diabetes: A comprehensive real-world data","volume":"32","author":"Ha","year":"2021","journal-title":"Osteoporos. Int."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2337\/dc19-0925","article-title":"Vertebral Fractures in Individuals with Type 2 Diabetes: More Than Skeletal Complications Alone","volume":"43","author":"Koromani","year":"2020","journal-title":"Diabetes Care"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S2213-8587(15)00283-1","article-title":"Type 2 diabetes and the skeleton: New insights into sweet bones","volume":"4","author":"Shanbhogue","year":"2016","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1210\/js.2019-00160","article-title":"Advanced Glycation End Products (AGEs), Receptor for AGEs, Diabetes, and Bone: Review of the Literature","volume":"3","author":"Asadipooya","year":"2019","journal-title":"J. Endocr. Soc."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1007\/s00198-020-05344-w","article-title":"Incidence of fractures in patients with type 1 diabetes mellitus-a retrospective study with 4420 patients","volume":"31","author":"Stumpf","year":"2020","journal-title":"Osteoporos. Int."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1210\/clinem\/dgz153","article-title":"Bone Mineral Density across the Lifespan in Patients with Type 1 Diabetes","volume":"105","author":"Gallo","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1007\/s00198-017-4097-x","article-title":"Bone mineral density at femoral neck and lumbar spine in adults with type 1 diabetes: A meta-analysis and review of the literature","volume":"28","author":"Shah","year":"2017","journal-title":"Osteoporos. Int."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s10654-012-9674-x","article-title":"Association between bone mineral density and type 2 diabetes mellitus: A meta-analysis of observational studies","volume":"27","author":"Ma","year":"2012","journal-title":"Eur. J. Epidemiol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1007\/s00198-018-4650-2","article-title":"Diagnosis and management of bone fragility in diabetes: An emerging challenge","volume":"29","author":"Ferrari","year":"2018","journal-title":"Osteoporos. Int."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1210\/clinem\/dgab490","article-title":"Type 2 diabetes and Change in Total Hip Bone Area and Bone Mineral Density in Elderly Swedish Men and Women","volume":"106","author":"Mitchell","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/s41574-021-00555-5","article-title":"Update on the pathogenesis and treatment of skeletal fragility in type 2 diabetes mellitus","volume":"17","author":"Khosla","year":"2021","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"107411","DOI":"10.1016\/j.jdiacomp.2019.107411","article-title":"Fracture risk in type 1 diabetes: Think beyond bone mineral density","volume":"33","author":"Shah","year":"2019","journal-title":"J. Diabetes Complicat."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1210\/jc.2012-3118","article-title":"TBS (trabecular bone score) and diabetes-related fracture risk","volume":"98","author":"Leslie","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jocd.2020.05.009","article-title":"Bone Measures by Dual-Energy X-ray Absorptiometry and Peripheral Quantitative Computed Tomography in Young Women with Type 1 Diabetes Mellitus","volume":"24","author":"Jiang","year":"2021","journal-title":"J. Clin. Densitom."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"599316","DOI":"10.3389\/fendo.2021.599316","article-title":"Longitudinal Evolution of Bone Microarchitecture and Bone Strength in Type 2 Diabetic Postmenopausal Women With and Without History of Fragility Fractures-A 5-Year Follow-Up Study Using High Resolution Peripheral Quantitative Computed Tomography","volume":"12","author":"Heilmeier","year":"2021","journal-title":"Front. Endocrinol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1007\/s00198-018-4532-7","article-title":"Assessment of bone quality in patients with diabetes mellitus","volume":"29","author":"Jiang","year":"2018","journal-title":"Osteoporos. Int."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1007\/s00125-005-1786-3","article-title":"Relative fracture risk in patients with diabetes mellitus, and the impact of insulin and oral antidiabetic medication on relative fracture risk","volume":"48","author":"Vestergaard","year":"2005","journal-title":"Diabetologia"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.2337\/dc12-1188","article-title":"High bone mineral density and fracture risk in type 2 diabetes as skeletal complications of inadequate glucose control: The Rotterdam Study","volume":"36","author":"Oei","year":"2013","journal-title":"Diabetes Care"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.diabres.2016.03.009","article-title":"Glycemic control and fracture risk in elderly patients with diabetes","volume":"115","author":"Conway","year":"2016","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.bone.2014.08.010","article-title":"Risk of fracture with thiazolidinediones: An updated meta-analysis of randomized clinical trials","volume":"68","author":"Zhu","year":"2014","journal-title":"Bone"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.2337\/diacare.27.7.1547","article-title":"Effect of alendronate on bone mineral density and biochemical markers of bone turnover in type 2 diabetic women: The fracture intervention trial","volume":"27","author":"Keegan","year":"2004","journal-title":"Diabetes Care"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s12020-018-1548-x","article-title":"Efficacy of anti-osteoporotic medications in patients with type 1 and 2 diabetes mellitus: A systematic review","volume":"60","author":"Anagnostis","year":"2018","journal-title":"Endocrine"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"e10346","DOI":"10.1002\/jbm4.10346","article-title":"Abaloparatide in postmenopausal women with osteoporosis and type 2 diabetes: A post hoc analysis of the ACTIVE study","volume":"4","author":"Dhaliwal","year":"2020","journal-title":"JBMR Plus"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"4602129","DOI":"10.1155\/2017\/4602129","article-title":"Male Hypogonadism and Osteoporosis: The Effects, Clinical Consequences, and Treatment of Testosterone Deficiency in Bone Health","volume":"2017","author":"Golds","year":"2017","journal-title":"Int. J. Endocrinol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1530\/eje.1.02088","article-title":"Osteoporosis and male age-related hypogonadism: Role of sex steroids on bone (patho)physiology","volume":"154","author":"Rochira","year":"2006","journal-title":"Eur. J. Endocrinol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1210\/jc.2003-031110","article-title":"Exogenous testosterone or testosterone with finasteride increases bone mineral density in older men with low serum testosterone","volume":"89","author":"Amory","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1001\/jamainternmed.2016.9539","article-title":"Effect of Testosterone Treatment on Volumetric Bone Density and Strength in Older Men With Low Testosterone: A Controlled Clinical Trial","volume":"177","author":"Snyder","year":"2017","journal-title":"JAMA Intern. Med."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1002\/jbmr.2273","article-title":"Postsurgical hypoparathyroidism--risk of fractures, psychiatric diseases, cancer, cataract, and infections","volume":"29","author":"Underbjerg","year":"2014","journal-title":"J. Bone Miner. Res."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Mendon\u00e7a, M.L., Pereira, F.A., Nogueira-Barbosa, M.H., Monsignore, L.M., Teixeira, S.R., Watanabe, P.C., Maciel, L.M., and de Paula, F.J. (2013). Increased vertebral morphometric fracture in patients with postsurgical hypoparathyroidism despite normal bone mineral density. BMC Endocr. Disord., 13.","DOI":"10.1186\/1472-6823-13-1"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1007\/s00198-021-05966-8","article-title":"Fracture risk in hypoparathyroidism: A systematic review and meta-analysis","volume":"32","author":"Pal","year":"2021","journal-title":"Osteoporos. Int."},{"key":"ref_87","first-page":"251","article-title":"Vertebral Fractures and Bone Mineral Density in Patients With Idiopathic Hypoparathyroidism on Long-Term Follow-Up","volume":"102","author":"Chawla","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1002\/jbmr.2501","article-title":"The Epidemiology of Nonsurgical Hypoparathyroidism in Denmark: A Nationwide Case Finding Study","volume":"30","author":"Underbjerg","year":"2015","journal-title":"J. Bone Miner. Res."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s00198-016-3750-0","article-title":"Bone imaging in hypoparathyroidism","volume":"28","author":"Silva","year":"2017","journal-title":"Osteoporos. Int."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s12020-016-1101-8","article-title":"Skeletal changes after restoration of the euparathyroid state in patients with hypoparathyroidism and primary hyperparathyroidism","volume":"55","author":"Cipriani","year":"2017","journal-title":"Endocrine"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1210\/clinem\/dgab076","article-title":"Vertebral Fracture Assessment in Postmenopausal Women with Postsurgical Hypoparathyroidism","volume":"106","author":"Cipriani","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"5795","DOI":"10.1210\/jc.2019-00698","article-title":"Predictors of Poor Bone Microarchitecture Assessed by Trabecular Bone Score in Postsurgical Hypoparathyroidism","volume":"104","author":"Sakane","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"4655","DOI":"10.1210\/jc.2003-030470","article-title":"Effects of an excess and a deficiency of endogenous parathyroid hormone on volumetric bone mineral density and bone geometry determined by peripheral quantitative computed tomography in female subjects","volume":"88","author":"Chen","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/jbmr.2609","article-title":"Noninvasive Assessment of Skeletal Microstructure and Estimated Bone Strength in Hypoparathyroidism","volume":"31","author":"Cusano","year":"2016","journal-title":"J. Bone Miner. Res."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00198-009-0945-7","article-title":"Assessment of trabecular and cortical architecture and mechanical competence of bone by high-resolution peripheral computed tomography: Comparison with transiliac bone biopsy","volume":"21","author":"Cohen","year":"2010","journal-title":"Osteoporos. Int."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s00198-019-05177-2","article-title":"PTH and bone material strength in hypoparathyroidism as measured by impact microindentation","volume":"31","author":"Starr","year":"2020","journal-title":"Osteoporos. Int."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"5601","DOI":"10.1210\/jc.2019-00893","article-title":"Therapy of Hypoparathyroidism With rhPTH(1-84): A Prospective, 8-Year Investigation of Efficacy and Safety","volume":"104","author":"Tay","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S2213-8587(13)70106-2","article-title":"Efficacy and safety of recombinant human parathyroid hormone (1-84) in hypoparathyroidism (REPLACE): A double-blind, placebo-controlled, randomised, phase 3 study","volume":"1","author":"Mannstadt","year":"2013","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1210\/jc.2013-1239","article-title":"The effect of PTH(1-84) on quality of life in hypoparathyroidism","volume":"98","author":"Cusano","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1089\/thy.2017.0309","article-title":"American Thyroid Association Statement on Postoperative Hypoparathyroidism: Diagnosis, Prevention, and Management in Adults","volume":"28","author":"Orloff","year":"2018","journal-title":"Thyroid"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"206","DOI":"10.4103\/ijem.IJEM_579_19","article-title":"Parathyroid Hormone Replacement versus Oral Calcium and Active Vitamin D Supplementation in Hypoparathyroidism: A Meta-analysis","volume":"24","author":"Palui","year":"2020","journal-title":"Indian J. Endocrinol. Metab."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1080\/01926230601072301","article-title":"Defining a noncarcinogenic dose of recombinant human parathyroid hormone 1-84 in a 2-year study in Fischer 344 rats","volume":"34","author":"Jolette","year":"2006","journal-title":"Toxicol. Pathol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1002\/jbmr.1800","article-title":"Safety of osteoanabolic therapy: A decade of experience","volume":"27","author":"Cipriani","year":"2012","journal-title":"J. Bone Miner. Res."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.surge.2020.06.008","article-title":"Parathyroid allotransplantation to treat post-thyroidectomy hypoparathyroidism: A review of case studies","volume":"19","author":"Parameswaran","year":"2021","journal-title":"Surgeon"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1007\/s00198-021-05822-9","article-title":"Risk of fractures in primary hyperparathyroidism: A systematic review and meta-analysis","volume":"32","author":"Rolighed","year":"2021","journal-title":"Osteoporos. Int."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"e10482","DOI":"10.1002\/jbm4.10482","article-title":"The Risk of Fractures in Primary Hyperparathyroidism: A Meta-Analysis","volume":"5","author":"Narayanan","year":"2021","journal-title":"JBMR Plus"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1002\/jbmr.3461","article-title":"Prevalence and Risk of Vertebral Fractures in Primary Hyperparathyroidism: A Nested Case-Control Study","volume":"33","author":"Bislev","year":"2018","journal-title":"J. Bone Miner. Res."},{"key":"ref_108","first-page":"83","article-title":"Bone Analysis by the Trabecular Bone Score and 3D-DXA in Postmenopausal Women with Primary Hyperparathyroidism","volume":"28","year":"2021","journal-title":"Endocr. Pract."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1210\/clinem\/dgab317","article-title":"DXA-Based Bone Strain Index: A New Tool to Evaluate Bone Quality in Primary Hyperparathyroidism","volume":"106","author":"Tabacco","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1002\/jbmr.1841","article-title":"Primary hyperparathyroidism is associated with abnormal cortical and trabecular microstructure and reduced bone stiffness in postmenopausal women","volume":"28","author":"Stein","year":"2013","journal-title":"J. Bone Miner. Res."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1002\/jbmr.98","article-title":"Effects on bone geometry, density, and microarchitecture in the distal radius but not the tibia in women with primary hyperparathyroidism: A case-control study using HR-pQCT","volume":"25","author":"Hansen","year":"2010","journal-title":"J. Bone Miner. Res."},{"key":"ref_112","first-page":"N95","article-title":"Primary hyperparathyroidism: Lessons from bone histomorphometry","volume":"17","author":"Eriksen","year":"2002","journal-title":"J. Bone Miner. Res."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"e2527","DOI":"10.1210\/clinem\/dgab207","article-title":"Bone Material Strength Index as Measured by Impact Microindentation is Low in Patients with Primary Hyperparathyroidism","volume":"106","author":"Schoeb","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1055\/s-0043-125334","article-title":"Long-Term Skeletal Outcomes of Primary Hyperparathyroidism Patients After Treatment with Parathyroidectomy: A Systematic Review and Meta-Analysis","volume":"50","author":"Zhang","year":"2018","journal-title":"Horm. Metab. Res."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s40618-020-01447-7","article-title":"Efficacy of parathyroidectomy compared with active surveillance in patients with mild asymptomatic primary hyperparathyroidism: A systematic review and meta-analysis of randomized-controlled studies","volume":"44","author":"Anagnostis","year":"2021","journal-title":"J. Endocrinol. Investig."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1210\/jc.2017-01932","article-title":"Skeletal Microstructure and Estimated Bone Strength Improve Following Parathyroidectomy in Primary Hyperparathyroidism","volume":"103","author":"Cusano","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"3607","DOI":"10.1210\/jc.2014-1417","article-title":"Medical management of primary hyperparathyroidism: Proceedings of the fourth International Workshop on the Management of Asymptomatic Primary Hyperparathyroidism","volume":"99","author":"Marcocci","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/s00394-002-0383-1","article-title":"The effects of calcium supplementation to patients with primary hyperparathyroidism and a low calcium intake","volume":"41","author":"Jorde","year":"2002","journal-title":"Eur. J. Nutr."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1089\/thy.2020.0084","article-title":"Consequences of Hyperthyroidism and Its Treatment for Bone Microarchitecture Assessed by High-Resolution Peripheral Quantitative Computed Tomography","volume":"31","author":"Nicolaisen","year":"2021","journal-title":"Thyroid"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s12020-019-02110-9","article-title":"Association of subclinical thyroid dysfunction with bone mineral density and fracture: A meta-analysis of prospective cohort studies","volume":"67","author":"Zhu","year":"2020","journal-title":"Endocrine"},{"key":"ref_121","first-page":"3655","article-title":"Effect of TSH Suppression Therapy on Bone Mineral Density in Differentiated Thyroid Cancer: A Systematic Review and Meta-analysis","volume":"106","author":"Ku","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Delitala, A.P., Scuteri, A., and Doria, C. (2020). Thyroid Hormone Diseases and Osteoporosis. J. Clin. Med., 9.","DOI":"10.3390\/jcm9041034"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1507\/endocrj.50.1","article-title":"Osteoporosis is more prevalent in adrenal than in pituitary Cushing\u2019s syndrome","volume":"50","author":"Ohmori","year":"2003","journal-title":"Endocr. J."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1210\/jc.2002-021518","article-title":"Gender-related differences in the presentation and course of Cushing\u2019s disease","volume":"88","author":"Moro","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/cen.12812","article-title":"Bone density and microarchitecture in endogenous hypercortisolism","volume":"83","author":"Madeira","year":"2015","journal-title":"Clin. Endocrinol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S2213-8587(21)00235-7","article-title":"Consensus on diagnosis and management of Cushing\u2019s disease: A guideline update","volume":"9","author":"Fleseriu","year":"2021","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1210\/jc.2005-0582","article-title":"Bone demineralization and vertebral fractures in endogenous cortisol excess: Role of disease etiology and gonadal status","volume":"91","author":"Pivonello","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"e2726","DOI":"10.1210\/clinem\/dgaa263","article-title":"Bone Evaluation by High-Resolution Peripheral Quantitative Computed Tomography in Patients with Adrenal Incidentaloma","volume":"105","author":"Moraes","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1210\/jc.2017-02043","article-title":"Lower Trabecular Bone Score in Patients with Primary Aldosteronism: Human Skeletal Deterioration by Aldosterone Excess","volume":"103","author":"Kim","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1210\/jc.2017-00169","article-title":"Lower Bone Mass and Higher Bone Resorption in Pheochromocytoma: Importance of Sympathetic Activity on Human Bone","volume":"102","author":"Kim","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"115607","DOI":"10.1016\/j.bone.2020.115607","article-title":"Role of deteriorated bone quality in the development of osteoporosis in pheochromocytoma and paraganglioma","volume":"142","author":"Umakoshi","year":"2021","journal-title":"Bone"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"e475","DOI":"10.1210\/clinem\/dgab712","article-title":"Increased Prevalence of Fractures in Congenital Adrenal Hyperplasia: A Swedish Population-Based National Cohort Study","volume":"107","author":"Falhammar","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1210\/jc.2014-2937","article-title":"Bone turnover, bone mineral density, and fracture risk in acromegaly: A meta-analysis","volume":"100","author":"Mazziotti","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1210\/clinem\/dgab260","article-title":"Impaired Bone Microarchitecture in Premenopausal Women with Acromegaly: The Possible Role of Wnt Signaling","volume":"106","author":"Silva","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1210\/er.2007-0036","article-title":"Growth hormone, insulin-like growth factors, and the skeleton","volume":"29","author":"Giustina","year":"2008","journal-title":"Endocr. Rev."},{"key":"ref_136","first-page":"D1","article-title":"Should patients with adult GH deficiency receive GH replacement?","volume":"186","author":"Johannsson","year":"2021","journal-title":"Eur. J. Endocrinol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1210\/jc.2014-2912","article-title":"Increased serum and bone matrix levels of the secreted Wnt antagonist DKK-1 in patients with growth hormone deficiency in response to growth hormone treatment","volume":"100","author":"Ueland","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jocd.2019.02.003","article-title":"Celiac Disease and Bone Health in Children and Adolescents: A Systematic Review and Meta-Analysis","volume":"23","author":"Fedewa","year":"2020","journal-title":"J. Clin. Densitom."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.cgh.2013.06.016","article-title":"High prevalence of osteoporosis in patients with chronic pancreatitis: A systematic review and meta-analysis","volume":"12","author":"Duggan","year":"2014","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1007\/s10067-017-3844-x","article-title":"Association between primary biliary cholangitis and osteoporosis: Meta-analysis","volume":"36","author":"Fan","year":"2017","journal-title":"Clin. Rheumatol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1016\/j.clnu.2017.07.018","article-title":"Osteoporosis in patients with intestinal insufficiency and intestinal failure: Prevalence and clinical risk factors","volume":"37","author":"Nygaard","year":"2018","journal-title":"Clin. Nutr."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"347","DOI":"10.5551\/jat.RV16007","article-title":"Transporters for the intestinal absorption of cholesterol, vitamin E, and vitamin K","volume":"24","author":"Yamanashi","year":"2017","journal-title":"J. Atheroscler. Thromb."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.1007\/s13197-017-2840-0","article-title":"Factors influencing the absorption of vitamin D in GIT: An overview","volume":"54","author":"Maurya","year":"2017","journal-title":"J. Food Sci. Technol."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/j.1523-1755.2004.00790.x","article-title":"Fat malabsorption induced by gastrointestinal lipase inhibitor leads to an increase in urinary oxalate excretion","volume":"66","author":"Ferraz","year":"2004","journal-title":"Kidney Int."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12937-019-0434-6","article-title":"Prevalence of osteoporosis and osteopenia in men and premenopausal women with celiac disease: A systematic review","volume":"18","author":"Ganji","year":"2019","journal-title":"Nutr. J."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/S0140-6736(99)01990-X","article-title":"Osteopenia in patients with clinically silent coeliac disease warrants screening","volume":"354","author":"Mustalahti","year":"1999","journal-title":"Lancet"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.3748\/wjg.v13.i21.2978","article-title":"Prevalence of IgA-antiendomysial antibody in a patient cohort with idiopathic low bone mineral density","volume":"13","author":"Karakan","year":"2007","journal-title":"World J. Gastroenterol."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"813","DOI":"10.18203\/2349-3933.ijam20162611","article-title":"Body mass index in celiac disease and effect of a gluten-free diet on body mass index","volume":"3","author":"Siddh","year":"2016","journal-title":"Int. J. Adv. Med."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S8756-3282(99)00171-4","article-title":"Bone recovery after a gluten-free diet: A 5-year follow-up study","volume":"25","author":"Kemppainen","year":"1999","journal-title":"Bone"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"e221","DOI":"10.1097\/MCG.0000000000001032","article-title":"Alterations of Inflammatory and Matrix Production Indices in Celiac Disease With Low Bone Mass on Long-term Gluten-free Diet","volume":"53","author":"Bergonzi","year":"2019","journal-title":"J. Clin. Gastroenterol."},{"key":"ref_151","doi-asserted-by":"crossref","unstructured":"Vujasinovic, M., Nezirevic Dobrijevic, L., Asplund, E., Rutkowski, W., Dugic, A., Kahn, M., Dahlman, I., Saaf, M., Hagstrom, H., and Lohr, J.M. (2021). Low Bone Mineral Density and Risk for Osteoporotic Fractures in Patients with Chronic Pancreatitis. Nutrients, 13.","DOI":"10.3390\/nu13072386"},{"key":"ref_152","first-page":"616","article-title":"Impact of cystic fibrosis on bone health","volume":"16","author":"Haworth","year":"2010","journal-title":"Curr. Opin. Pulm. Med."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/ncp.10113","article-title":"Bacteria, Bones, and Stones: Managing Complications of Short Bowel Syndrome","volume":"33","author":"Johnson","year":"2018","journal-title":"Nutr. Clin. Pract."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1177\/0884533612470145","article-title":"Osteoporosis in chronic liver disease","volume":"28","author":"Yadav","year":"2013","journal-title":"Nutr. Clin. Pract."},{"key":"ref_155","first-page":"1397","article-title":"Osteoporosis in patients with primary biliary cirrhosis","volume":"22","author":"Wariaghli","year":"2010","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.jhep.2004.11.035","article-title":"Severity of cholestasis and advanced histological stage but not menopausal status are the major risk factors for osteoporosis in primary biliary cirrhosis","volume":"42","author":"Guanabens","year":"2005","journal-title":"J. Hepatol."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S0344-0338(89)80138-4","article-title":"Bone changes in alcoholic cirrhosis of the liver. A histomorphometric study","volume":"184","author":"Chappard","year":"1989","journal-title":"Pathol. Res. Pract."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"e2276","DOI":"10.1097\/MD.0000000000002276","article-title":"Association Between Chronic Hepatitis B Virus Infection and Risk of Osteoporosis: A Nationwide Population-Based Study","volume":"94","author":"Chen","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"e2086","DOI":"10.1097\/MD.0000000000002086","article-title":"Relation Between Hepatitis C Virus Exposure and Risk of Osteoporosis: A Nationwide Population-Based Study","volume":"94","author":"Chen","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.cgh.2019.05.043","article-title":"A System to Determine Risk of Osteoporosis in Patients with Autoimmune Hepatitis","volume":"18","author":"Schmidt","year":"2020","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00198-008-0701-4","article-title":"Association between iron overload and osteoporosis in patients with hereditary hemochromatosis","volume":"20","author":"Valenti","year":"2009","journal-title":"Osteoporos. Int."},{"key":"ref_162","doi-asserted-by":"crossref","unstructured":"Ehnert, S., Aspera-Werz, R.H., Ruo\u00df, M., Dooley, S., Hengstler, J.G., Nadalin, S., Relja, B., Badke, A., and Nussler, A.K. (2019). Hepatic Osteodystrophy-Molecular Mechanisms Proposed to Favor Its Development. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20102555"},{"key":"ref_163","first-page":"512","article-title":"Hepatic Osteodystrophy: A Global (Re)View of the Problem","volume":"56","author":"Barbu","year":"2017","journal-title":"Acta Clin. Croat."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/MEG.0000000000001981","article-title":"Is there an association between peptic ulcer disease and osteoporosis: A systematic review and cumulative analysis","volume":"33","author":"Zhao","year":"2021","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/jbmr.4162","article-title":"Infection by CagA-Positive Helicobacter pylori Strains and Bone Fragility: A Prospective Cohort Study","volume":"36","author":"Gennari","year":"2021","journal-title":"J. Bone Miner. Res."},{"key":"ref_166","first-page":"1756284819862152","article-title":"Metabolic bone disease in patients diagnosed with inflammatory bowel disease from Spain","volume":"12","author":"Verdejo","year":"2019","journal-title":"Therap. Adv. Gastroenterol."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"20345","DOI":"10.1038\/s41598-021-99669-z","article-title":"Assessment of bone quality with trabecular bone score in patients with inflammatory bowel disease","volume":"11","author":"Soare","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_168","doi-asserted-by":"crossref","unstructured":"Haschka, J., Kraus, D.A., Behanova, M., Huber, S., Bartko, J., Schanda, J.E., Meier, P., Bahrami, A., Zandieh, S., and Zwerina, J. (2020). Fractal-Based Analysis of Bone Microstructure in Crohn\u2019s Disease: A Pilot Study. J. Clin. Med., 9.","DOI":"10.3390\/jcm9124116"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jocd.2018.07.010","article-title":"Does the Antitumor Necrosis Factor-alpha Therapy Decrease the Vertebral Fractures Occurrence in Inflammatory Bowel Disease?","volume":"22","year":"2019","journal-title":"J. Clin. Densitom."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"795","DOI":"10.7326\/0003-4819-133-10-200011210-00012","article-title":"The incidence of fracture among patients with inflammatory bowel disease. A population-based cohort study","volume":"133","author":"Bernstein","year":"2000","journal-title":"Ann. Intern. Med."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/MCG.0000000000001031","article-title":"Risk of Fractures in Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis","volume":"53","author":"Komaki","year":"2019","journal-title":"J. Clin. Gastroenterol."},{"key":"ref_172","first-page":"e5810","article-title":"Inflammatory Bowel Disease and Risk of Osteoporotic Fractures: A Meta-Analysis","volume":"11","author":"Hidalgo","year":"2019","journal-title":"Cureus"},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/MOG.0000000000000710","article-title":"Bone loss in patients with inflammatory bowel disease: Cause, detection and treatment","volume":"37","author":"Bravenboer","year":"2021","journal-title":"Curr. Opin. Gastroenterol."},{"key":"ref_174","doi-asserted-by":"crossref","unstructured":"Morgan, S., Hooper, K.M., Milne, E.M., Farquharson, C., Stevens, C., and Staines, K.A. (2019). Azathioprine Has a Deleterious Effect on the Bone Health of Mice with DSS-Induced Inflammatory Bowel Disease. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20236085"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.bone.2017.07.011","article-title":"Increased bone matrix mineralization in treatment-naive children with inflammatory bowel disease","volume":"105","author":"Misof","year":"2017","journal-title":"Bone"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1053\/j.gastro.2010.09.007","article-title":"Histomorphometric analysis reveals reduced bone mass and bone formation in patients with quiescent Crohn\u2019s disease","volume":"140","author":"Oostlander","year":"2011","journal-title":"Gastroenterology"},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/ajg.2016.537","article-title":"ACG Clinical Guideline: Preventive Care in Inflammatory Bowel Disease","volume":"112","author":"Farraye","year":"2017","journal-title":"Am. J. Gastroenterol."},{"key":"ref_178","unstructured":"(2021, December 01). IBD Checklists\u2014Cornerstone Health. Available online: https:\/\/www.cornerstoneshealth.org\/ibd-checklists."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/ibd\/izy341","article-title":"Findings of CT-Derived Bone Strength Assessment in Inflammatory Bowel Disease Patients Undergoing CT Enterography in Clinical Practice","volume":"25","author":"Maldonado","year":"2019","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1093\/ecco-jcc\/jjz057","article-title":"Early Initiation of Anti-TNF is Associated with Favourable Long-term Outcome in Crohn\u2019s Disease: 10-Year-Follow-up Data from the Swiss IBD Cohort Study","volume":"13","author":"Frei","year":"2019","journal-title":"J. Crohns Colitis"},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"e5861","DOI":"10.1097\/MD.0000000000005861","article-title":"Efficacy and safety of bisphosphonates in management of low bone density in inflammatory bowel disease: A meta-analysis","volume":"96","author":"Yao","year":"2017","journal-title":"Medicine"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"BSR20192317","DOI":"10.1042\/BSR20192317","article-title":"Effects of emodin on inflammatory bowel disease-related osteoporosis","volume":"40","author":"Luo","year":"2020","journal-title":"Biosci. Rep."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1159\/000517909","article-title":"Association between Irritable Bowel Syndrome and Risk of Osteoporosis in Korean Premenopausal Women","volume":"30","author":"Lee","year":"2021","journal-title":"Med. Princ. Pract."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1007\/s00198-020-05318-y","article-title":"The association between irritable bowel syndrome and osteoporosis: A systematic review and meta-analysis","volume":"31","author":"Wongtrakul","year":"2020","journal-title":"Osteoporos. Int."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1007\/s00774-021-01247-w","article-title":"Novel microbiota-related gene set enrichment analysis identified osteoporosis associated gut microbiota from autoimmune diseases","volume":"39","author":"Cao","year":"2021","journal-title":"J. Bone Miner. Metab."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/JLB.3MR0321-755R","article-title":"The microbiota-gut-bone axis and bone health","volume":"110","author":"Tu","year":"2021","journal-title":"J. Leukoc. Biol."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"87","DOI":"10.12938\/bmfh.18-006","article-title":"Effect of Bacillus subtilis C-3102 on bone mineral density in healthy postmenopausal Japanese women: A randomized, placebo-controlled, double-blind clinical trial","volume":"37","author":"Takimoto","year":"2018","journal-title":"Biosci. Microbiota Food Health"},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1007\/s10120-017-0777-7","article-title":"Risk of osteoporosis after gastrectomy in long-term gastric cancer survivors","volume":"21","author":"Yoo","year":"2018","journal-title":"Gastric Cancer"},{"key":"ref_189","doi-asserted-by":"crossref","unstructured":"Kim, H.W., Kim, Y.H., Han, K., Nam, G.E., Kim, G.S., Han, B.D., Lee, A., Ahn, J.Y., and Ko, B.J. (2014). Atrophic gastritis: A related factor for osteoporosis in elderly women. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0101852"},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"774","DOI":"10.3109\/00365521.2016.1141317","article-title":"Impaired skeletal health in patients with chronic atrophic gastritis","volume":"51","author":"Aasarod","year":"2016","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1007\/s00223-020-00798-w","article-title":"Bariatric Surgery and Osteoporosis","volume":"110","author":"Paccou","year":"2021","journal-title":"Calcif. Tissue Res."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"3709","DOI":"10.15419\/bmrat.v7i4.598","article-title":"Nutrition and osteoporosis prevention and treatment","volume":"7","author":"Hejazi","year":"2020","journal-title":"Biomed. Res. Ther."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1210\/jc.2010-2704","article-title":"The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: What clinicians need to know","volume":"96","author":"Ross","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_194","unstructured":"Institute of Medicine (US) Standing Committee on the Scientific Evaluation of Dietary Reference IntakesIntakes (1997). Dietary reference intakes. Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride, National Academies Press (US)."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.jamda.2013.05.021","article-title":"Evidence-based recommendations for optimal dietary protein intake in older people: A position paper from the PROT-AGE Study Group","volume":"14","author":"Bauer","year":"2013","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.maturitas.2014.07.005","article-title":"The role of dietary protein and vitamin D in maintaining musculoskeletal health in postmenopausal women: A consensus statement from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO)","volume":"79","author":"Rizzoli","year":"2014","journal-title":"Maturitas"},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s40520-020-01678-x","article-title":"Vitamin D supplementation: Upper limit for safety revisited?","volume":"33","author":"Rizzoli","year":"2021","journal-title":"Aging Clin. Exp. Res."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"624","DOI":"10.7861\/clinmedicine.10-6-624","article-title":"Malnutrition: Causes and consequences","volume":"10","author":"Saunders","year":"2010","journal-title":"Clin. Med."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1080\/17446651.2019.1575727","article-title":"Understanding and managing secondary osteoporosis","volume":"14","author":"Colangelo","year":"2019","journal-title":"Expert Rev. Endocrinol. Metab."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S2213-8587(21)00119-4","article-title":"Nutritional intake and bone health","volume":"9","author":"Rizzoli","year":"2021","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"628740","DOI":"10.1155\/2015\/628740","article-title":"Evidence for the adverse effect of starvation on bone quality: A review of the literature","volume":"2015","author":"Kueper","year":"2015","journal-title":"Int. J. Endocrinol."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/ajcn\/68.3.599","article-title":"Adaptive reduction in basal metabolic rate in response to food deprivation in humans: A role for feedback signals from fat stores","volume":"68","author":"Dulloo","year":"1998","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"299","DOI":"10.4158\/EP-2018-0419","article-title":"Exposure to famine in early life and the risk of osteoporosis in adulthood: A prospective study","volume":"25","author":"Zong","year":"2019","journal-title":"Endocr. Pract."},{"key":"ref_204","first-page":"345","article-title":"Clinical manifestations of \u201cHunger Disease\u201d among children in the ghettos during the Holocaust","volume":"142","author":"Even","year":"2003","journal-title":"Harefuah"},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"e0004","DOI":"10.5041\/RMMJ.10138","article-title":"Hunger whilst \u201cin utero\u201d programming adult osteoporosis","volume":"5","author":"Weisz","year":"2014","journal-title":"Rambam Maimonides Med. J."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1007\/s00198-007-0389-x","article-title":"Higher prevalence of osteoporosis among female Holocaust survivors","volume":"18","author":"Marcus","year":"2007","journal-title":"Osteoporos. Int."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1093\/ije\/dym149","article-title":"Experience of famine and bone health in post-menopausal women","volume":"36","author":"Kin","year":"2007","journal-title":"Int. J. Epidemiol."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1210\/edrv.22.4.0437","article-title":"Vitamin D deficiency and secondary hyperparathyroidism in the elderly: Consequences for bone loss and fractures and therapeutic implications","volume":"22","author":"Lips","year":"2001","journal-title":"Endocr. Rev."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1002\/jbmr.3442","article-title":"25-hydroxyvitamin D threshold for the effects of vitamin D supplements on bone density: Secondary analysis of a randomized controlled trial","volume":"33","author":"Macdonald","year":"2018","journal-title":"J. Bone Miner. Res."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/joim.12651","article-title":"Effect of monthly high-dose vitamin D on bone density in community-dwelling older adults substudy of a randomized controlled trial","volume":"282","author":"Reid","year":"2017","journal-title":"J. Intern. Med."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S2213-8587(18)30265-1","article-title":"Effects of vitamin D supplementation on musculoskeletal health: A systematic review, meta-analysis, and trial sequential analysis","volume":"6","author":"Bolland","year":"2018","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S0140-6736(13)61647-5","article-title":"Effects of vitamin D supplements on bone mineral density: A systematic review and meta-analysis","volume":"383","author":"Reid","year":"2014","journal-title":"Lancet"},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1001\/jama.2017.19344","article-title":"Association between calcium or vitamin D supplementation and fracture incidence in community-dwelling older adults: A systematic review and meta-analysis","volume":"318","author":"Zhao","year":"2017","journal-title":"JAMA"},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1001\/jama.2019.11889","article-title":"Effect of high-dose vitamin D supplementation on volumetric bone density and bone strength: A randomized clinical trial","volume":"322","author":"Burt","year":"2019","journal-title":"JAMA"},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"10817","DOI":"10.1039\/D0FO00787K","article-title":"Effects of combined calcium and vitamin D supplementation on osteoporosis in postmenopausal women: A systematic review and meta-analysis of randomized controlled trials","volume":"11","author":"Liu","year":"2020","journal-title":"Food Funct."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00198-015-3386-5","article-title":"Calcium plus vitamin D supplementation and risk of fractures: An updated meta-analysis from the National Osteoporosis Foundation","volume":"27","author":"Weaver","year":"2016","journal-title":"Osteoporos. Int."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1359\/jbmr.091004","article-title":"Obesity and fractures in postmenopausal women","volume":"25","author":"Premaor","year":"2010","journal-title":"J. Bone Miner. Res."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/jbmr.2754","article-title":"Decline in bone mass during weight loss: A cause for concern?","volume":"31","author":"Schafer","year":"2016","journal-title":"J. Bone Miner. Res."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1080\/21551197.2018.1564721","article-title":"Weight loss-induced reduction of bone mineral density in older adults with obesity","volume":"38","author":"Jiang","year":"2019","journal-title":"J. Nutr. Gerontol. Geriatr."},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.amjmed.2011.06.013","article-title":"Obesity is not protective against fracture in postmenopausal women: GLOW","volume":"124","author":"Compston","year":"2011","journal-title":"Am. J. Med."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/jbmr.1483","article-title":"Effect of 1 year of an intentional weight loss intervention on bone mineral density in type 2 diabetes: Results from the Look AHEAD randomized trial","volume":"27","author":"Schwartz","year":"2012","journal-title":"J. Bone Miner. Res."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.2337\/dc14-0762","article-title":"The Look AHEAD Trial: Bone loss at 4-year follow-up in type 2 diabetes","volume":"37","author":"Lipkin","year":"2014","journal-title":"Diabetes Care"},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1590\/S0004-27302010000200011","article-title":"Bariatric surgery and bone metabolism: A systematic review","volume":"54","author":"Vasconcelos","year":"2010","journal-title":"Arq. Bras. Endocrinol. Metabol."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11695-008-9638-0","article-title":"Changes in bone mineral density, body composition and adiponectin levels in morbidly obese patients after bariatric surgery","volume":"19","author":"Carrasco","year":"2009","journal-title":"Obes. Surg."},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/BF01625450","article-title":"Secondary hyperparathyroidism and osteopenia in women following gastric exclusion surgery for obesity","volume":"1","author":"Shaker","year":"1991","journal-title":"Osteoporos. Int."},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/jbm4.10048","article-title":"Bone health after bariatric surgery","volume":"2","author":"Gagnon","year":"2018","journal-title":"JBMR Plus"},{"key":"ref_227","unstructured":"American Psychiatric Association, A. (1980). Diagnostic and Statistical Manual of Mental Disorders, American Psychiatric Association."},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.amjmed.2015.06.031","article-title":"Medical complications of anorexia nervosa and bulimia","volume":"129","author":"Westmoreland","year":"2016","journal-title":"Am. J. Med."},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/eat.10101","article-title":"Fractures in patients with anorexia nervosa, bulimia nervosa, and other eating disorders\u2014a nationwide register study","volume":"32","author":"Vestergaard","year":"2002","journal-title":"Int. J. Eat. Disord."},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1001\/jama.1991.03460090081037","article-title":"The clinical course of osteoporosis in anorexia nervosa: A longitudinal study of cortical bone mass","volume":"265","author":"Rigotti","year":"1991","journal-title":"JAMA"},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"133","DOI":"10.11005\/jbm.2019.26.3.133","article-title":"Anorexia nervosa and osteoporosis: Pathophysiology and treatment","volume":"26","author":"Steinman","year":"2019","journal-title":"J. Bone Metab."},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s11914-009-0014-3","article-title":"Bone markers in osteoporosis","volume":"7","author":"Garnero","year":"2009","journal-title":"Curr. Osteoporos. Rep."},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jpsychores.2017.05.011","article-title":"Pharmacological treatment options for low bone mineral density and secondary osteoporosis in anorexia nervosa: A systematic review of the literature","volume":"98","author":"Robinson","year":"2017","journal-title":"J. Psychosom. Res."},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1210\/jc.2011-0380","article-title":"Effects of risedronate and low-dose transdermal testosterone on bone mineral density in women with anorexia nervosa: A randomized, placebo-controlled study","volume":"96","author":"Miller","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"3903","DOI":"10.1210\/jc.2003-031885","article-title":"Effects of risedronate on bone density in anorexia nervosa","volume":"89","author":"Miller","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1002\/jbmr.447","article-title":"Physiologic estrogen replacement increases bone density in adolescent girls with anorexia nervosa","volume":"26","author":"Misra","year":"2011","journal-title":"J. Bone Miner. Res."},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1002\/jbmr.4420","article-title":"Sequential Therapy with Recombinant Human IGF-1 Followed by Risedronate Increases Spine Bone Mineral Density in Women With Anorexia Nervosa: A Randomized, Placebo-Controlled Trial","volume":"36","author":"Haines","year":"2021","journal-title":"J. Bone Miner. Res."},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1210\/jc.2013-4105","article-title":"Teriparatide increases bone formation and bone mineral density in adult women with anorexia nervosa","volume":"99","author":"Fazeli","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_239","doi-asserted-by":"crossref","unstructured":"Napartivaumnuay, N., and Gramlich, L. (2017). The prevalence of vitamin D insufficiency and deficiency and their relationship with bone mineral density and fracture risk in adults receiving long-term home parenteral nutrition. Nutrients, 9.","DOI":"10.3390\/nu9050481"},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1177\/0148607193017003214","article-title":"Metabolic bone disease in adults receiving long-term parenteral nutrition: Longitudinal study with regional densitometry and bone biopsy","volume":"17","author":"Saitta","year":"1993","journal-title":"J. Parenter. Enter. Nutr."},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1177\/0148607195019006431","article-title":"Increase in lumbar spine bone mineral content in patients on long-term parenteral nutrition without vitamin D supplementation","volume":"19","author":"Verhage","year":"1995","journal-title":"J. Parenter. Enter. Nutr."},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1177\/0884533615609904","article-title":"Changes to the intestinal microbiome with parenteral nutrition: Review of a murine model and potential clinical implications","volume":"30","author":"Demehri","year":"2015","journal-title":"Nutr. Clin. Pract."},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1093\/ajcn\/38.2.264","article-title":"Amino acid-induced hypercalciuria in patients on total parenteral nutrition","volume":"38","author":"Bengoa","year":"1983","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.1016\/S0261-5614(03)80330-8","article-title":"Intravenous pamidronate improves bone mineral density in home parenteral nutrition patients","volume":"22","author":"Nishikawa","year":"2003","journal-title":"Clin. Nutr."},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1093\/ajcn\/76.2.482","article-title":"Effect of cyclical intravenous clodronate therapy on bone mineral density and markers of bone turnover in patients receiving home parenteral nutrition","volume":"76","author":"Haderslev","year":"2002","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/1054-139X(94)90506-1","article-title":"Carbonated beverages, dietary calcium, the dietary calcium\/phosphorus ratio, and bone fractures in girls and boys","volume":"15","author":"Wyshak","year":"1994","journal-title":"J. Adolesc. Health"},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1111\/j.1749-6632.1969.tb13011.x","article-title":"Influence of various nutrients and hormones on urinary divalent cation excretion","volume":"162","author":"Lindeman","year":"1969","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_248","first-page":"578","article-title":"Evidence that glucose ingestion inhibits net renal tubular reabsorption of calcium and magnesium in man","volume":"75","author":"Lemann","year":"1970","journal-title":"J. Lab. Clin. Med."},{"key":"ref_249","doi-asserted-by":"crossref","first-page":"E1303","DOI":"10.1152\/ajpendo.00582.2012","article-title":"Excessive fructose intake causes 1, 25-(OH) 2D3-dependent inhibition of intestinal and renal calcium transport in growing rats","volume":"304","author":"Douard","year":"2013","journal-title":"Am. J. Physiol.-Endocrinol. Metab."},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1083\/jcb.101.6.2210","article-title":"Cell-mediated extracellular acidification and bone resorption: Evidence for a low pH in resorbing lacunae and localization of a 100-kD lysosomal membrane protein at the osteoclast ruffled border","volume":"101","author":"Baron","year":"1985","journal-title":"J. Cell Biol."},{"key":"ref_251","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.bone.2005.11.024","article-title":"Osteoporosis: A still increasing prevalence","volume":"38","author":"Reginster","year":"2006","journal-title":"Bone"},{"key":"ref_252","first-page":"247","article-title":"Not salt but sugar as aetiological in osteoporosis: A review","volume":"115","author":"DiNicolantonio","year":"2018","journal-title":"Mo. Med."},{"key":"ref_253","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1093\/oxfordjournals.aje.a010277","article-title":"Effect of alcohol intake on bone mineral density in elderly women: The EPIDOS study","volume":"151","author":"Ganry","year":"2000","journal-title":"Am. J. Epidemiol."},{"key":"ref_254","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00198-011-1787-7","article-title":"Alcohol and bone: Review of dose effects and mechanisms","volume":"23","author":"Maurel","year":"2012","journal-title":"Osteoporos. Int."},{"key":"ref_255","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.bone.2011.06.001","article-title":"Low bone accrual is associated with osteocyte apoptosis in alcohol-induced osteopenia","volume":"49","author":"Maurel","year":"2011","journal-title":"Bone"},{"key":"ref_256","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jbspin.2011.10.004","article-title":"Cortical bone is more sensitive to alcohol dose effects than trabecular bone in the rat","volume":"79","author":"Maurel","year":"2012","journal-title":"Jt. Bone Spine"},{"key":"ref_257","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s00198-007-0492-z","article-title":"Relationships between fat and bone","volume":"19","author":"Reid","year":"2008","journal-title":"Osteoporos. Int."},{"key":"ref_258","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/acer.13000","article-title":"Alcohol: A simple nutrient with complex actions on bone in the adult skeleton","volume":"40","author":"Gaddini","year":"2016","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"ref_259","doi-asserted-by":"crossref","first-page":"282","DOI":"10.9758\/cpn.2018.16.3.282","article-title":"Increased Bone Mineral Density after Abstinence in Male Patients with Alcohol Dependence","volume":"16","author":"Song","year":"2018","journal-title":"Clin. Psychopharmacol. Neurosci."},{"key":"ref_260","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1111\/acer.13063","article-title":"Osteoprotegerin Levels Decrease in Abstinent Alcohol-Dependent Patients","volume":"40","author":"Malik","year":"2016","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"ref_261","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/acr.21796","article-title":"Prevalence of oral glucocorticoid usage in the United States: A general population perspective","volume":"65","author":"Overman","year":"2013","journal-title":"Arthritis Care Res. (Hoboken)"},{"key":"ref_262","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1359\/jbmr.2000.15.6.993","article-title":"Use of oral corticosteroids and risk of fractures","volume":"15","author":"Leufkens","year":"2000","journal-title":"J. Bone Miner. Res."},{"key":"ref_263","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1002\/art.11283","article-title":"Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy","volume":"48","author":"Laan","year":"2003","journal-title":"Arthritis Rheum."},{"key":"ref_264","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s001980170006","article-title":"Ten year probabilities of osteoporotic fractures according to BMD and diagnostic thresholds","volume":"12","author":"Kanis","year":"2001","journal-title":"Osteoporos. Int."},{"key":"ref_265","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/art.22294","article-title":"Fracture risk with intermittent high-dose oral glucocorticoid therapy","volume":"56","author":"Bracke","year":"2007","journal-title":"Arthritis Rheum."},{"key":"ref_266","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s11914-016-0308-1","article-title":"The Skeletal Effects of Inhaled Glucocorticoids","volume":"14","author":"Sutter","year":"2016","journal-title":"Curr. Osteoporos. Rep."},{"key":"ref_267","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1056\/NEJMoa002304","article-title":"Effects of inhaled glucocorticoids on bone density in premenopausal women","volume":"345","author":"Israel","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"ref_268","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S1542-3565(04)00662-7","article-title":"Bone mineral density in relation to efficacy and side effects of budesonide and prednisolone in Crohn\u2019s disease","volume":"3","author":"Schoon","year":"2005","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_269","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1001\/jamadermatol.2020.4968","article-title":"Association of Potent and Very Potent Topical Corticosteroids and the Risk of Osteoporosis and Major Osteoporotic Fractures","volume":"157","author":"Egeberg","year":"2021","journal-title":"JAMA Derm."},{"key":"ref_270","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/jcb.21414","article-title":"Dexamethasone promotes osteoclastogenesis by inhibiting osteoprotegerin through multiple levels","volume":"103","author":"Kondo","year":"2008","journal-title":"J. Cell. Biochem."},{"key":"ref_271","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/rheumatology\/32.suppl_2.11","article-title":"Differential effect of glucocorticoids on calcium absorption and bone mass","volume":"32","author":"Gennari","year":"1993","journal-title":"Br. J. Rheumatol."},{"key":"ref_272","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1359\/JBMR.041125","article-title":"Effects of low-dose prednisone on bone metabolism","volume":"20","author":"Ton","year":"2005","journal-title":"J. Bone Miner. Res."},{"key":"ref_273","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1210\/jc.2011-2757","article-title":"Clinical review: Do glucocorticosteroids alter vitamin D status? A systematic review with meta-analyses of observational studies","volume":"97","author":"Davidson","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_274","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.ecl.2012.04.004","article-title":"Glucocorticoid-induced osteoporosis and osteonecrosis","volume":"41","author":"Weinstein","year":"2012","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"key":"ref_275","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1002\/art.40137","article-title":"2017 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis","volume":"69","author":"Buckley","year":"2017","journal-title":"Arthritis Rheumatol."},{"key":"ref_276","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00198-014-2859-2","article-title":"Evaluation of the effect of selective serotonin reuptake inhibitors on bone mineral density: An observational cross-sectional study","volume":"26","author":"Ak","year":"2015","journal-title":"Osteoporos. Int."},{"key":"ref_277","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.1002\/art.24879","article-title":"Effects of teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: Thirty-six-month results of a randomized, double-blind, controlled trial","volume":"60","author":"Saag","year":"2009","journal-title":"Arthritis Rheum."},{"key":"ref_278","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.jamda.2016.12.003","article-title":"Use of Selective Serotonin Reuptake Inhibitors and Risk of Hip Fracture in the Elderly: A Case-Control Study in Taiwan","volume":"18","author":"Hung","year":"2017","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"ref_279","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1001\/jamapsychiatry.2017.0449","article-title":"Association of Mental Disorders and Related Medication Use With Risk for Major Osteoporotic Fractures","volume":"74","author":"Bolton","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"ref_280","doi-asserted-by":"crossref","first-page":"13461","DOI":"10.1038\/s41598-021-92821-9","article-title":"Use of serotonin reuptake inhibitors and risk of subsequent bone loss in a nationwide population-based cohort study","volume":"11","author":"Kang","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_281","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1038\/nm.4166","article-title":"Serotonin-reuptake inhibitors act centrally to cause bone loss in mice by counteracting a local anti-resorptive effect","volume":"22","author":"Ortuno","year":"2016","journal-title":"Nat. Med."},{"key":"ref_282","first-page":"378","article-title":"Osteopathies in antiepileptic long-term therapy (preliminary report)","volume":"116","author":"Kruse","year":"1968","journal-title":"Monatsschr. Kinderheilkd."},{"key":"ref_283","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jns.2013.05.005","article-title":"Bone disease during chronic antiepileptic drug therapy: General versus specific risk factors","volume":"331","author":"Beerhorst","year":"2013","journal-title":"J. Neurol. Sci."},{"key":"ref_284","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S1525-5050(03)00036-2","article-title":"Bone mineral density in an outpatient population receiving enzyme-inducing antiepileptic drugs","volume":"4","author":"Pack","year":"2003","journal-title":"Epilepsy Behav."},{"key":"ref_285","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/1531-8249(200003)47:3<385::AID-ANA18>3.0.CO;2-W","article-title":"Increased bone turnover in epileptic patients treated with carbamazepine","volume":"47","author":"Verrotti","year":"2000","journal-title":"Ann. Neurol."},{"key":"ref_286","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1046\/j.1528-1157.2002.13002.x","article-title":"Increased bone turnover in prepubertal, pubertal, and postpubertal patients receiving carbamazepine","volume":"43","author":"Verrotti","year":"2002","journal-title":"Epilepsia"},{"key":"ref_287","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1172\/JCI21867","article-title":"Possible involvement of pregnane X receptor-enhanced CYP24 expression in drug-induced osteomalacia","volume":"115","author":"Pascussi","year":"2005","journal-title":"J. Clin. Investig."},{"key":"ref_288","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1212\/01.wnl.0000310981.44676.de","article-title":"Bone health in young women with epilepsy after one year of antiepileptic drug monotherapy","volume":"70","author":"Pack","year":"2008","journal-title":"Neurology"},{"key":"ref_289","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1136\/bmj.4.5727.73","article-title":"Disturbance of calcium metabolism by anticonvulsant drugs","volume":"4","author":"Richens","year":"1970","journal-title":"Br. Med. J."},{"key":"ref_290","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0221-8747(80)90001-6","article-title":"Dynamic differences in trabecular bone remodeling between patients after jejuno-ileal bypass for obesity and epileptic patients receiving anticonvulsant therapy","volume":"2","author":"Mosekilde","year":"1980","journal-title":"Metab. Bone Dis. Relat. Res."},{"key":"ref_291","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1210\/jcem-58-6-1003","article-title":"Decreased serum ionized calcium and normal vitamin D metabolite levels with anticonvulsant drug treatment","volume":"58","author":"Weinstein","year":"1984","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_292","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1200\/jco.2006.24.18_suppl.511","article-title":"Effect of anastrozole on bone mineral density: 5-year results from the \u2018Arimidex\u2019, Tamoxifen, Alone or in Combination (ATAC) trial","volume":"24","author":"Coleman","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"ref_293","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.1200\/JCO.2005.05.4882","article-title":"Effect of letrozole versus placebo on bone mineral density in women with primary breast cancer completing 5 or more years of adjuvant tamoxifen: A companion study to NCIC CTG MA.17","volume":"24","author":"Perez","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"ref_294","first-page":"1623","article-title":"Immediate versus deferred treatment for advanced prostatic cancer: Initial results of the Medical Research Council trial. The Medical Research Council Prostate Cancer Working Party Investigators Group","volume":"158","author":"Walsh","year":"1997","journal-title":"J. Urol."},{"key":"ref_295","doi-asserted-by":"crossref","first-page":"7897","DOI":"10.1200\/JCO.2004.00.6908","article-title":"Gonadotropin-releasing hormone agonists and fracture risk: A claims-based cohort study of men with nonmetastatic prostate cancer","volume":"23","author":"Smith","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"ref_296","first-page":"E307","article-title":"Canadian Urological Association guideline on androgen deprivation therapy: Adverse events and management strategies","volume":"15","author":"Kokorovic","year":"2021","journal-title":"Can Urol. Assoc. J."},{"key":"ref_297","doi-asserted-by":"crossref","first-page":"690783","DOI":"10.1155\/2014\/690783","article-title":"The alliance of mesenchymal stem cells, bone, and diabetes","volume":"2014","author":"Napoli","year":"2014","journal-title":"Int. J. Endocrinol."},{"key":"ref_298","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.1210\/jc.2018-02539","article-title":"Effect of Insulin Resistance on BMD and Fracture Risk in Older Adults","volume":"104","author":"Napoli","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_299","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/nrendo.2016.153","article-title":"Mechanisms of diabetes mellitus-induced bone fragility","volume":"13","author":"Napoli","year":"2017","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_300","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.2337\/dc06-2606","article-title":"Thiazolidinedione treatment decreases bone mineral density in type 2 diabetic men","volume":"30","author":"Yaturu","year":"2007","journal-title":"Diabetes Care"},{"key":"ref_301","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1007\/s00198-020-05801-6","article-title":"Effect of dipeptidyl peptidase IV inhibitors, thiazolidinedione, and sulfonylurea on osteoporosis in patients with type 2 diabetes: Population-based cohort study","volume":"32","author":"Yang","year":"2021","journal-title":"Osteoporos. Int."},{"key":"ref_302","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1210\/jc.2015-1860","article-title":"Evaluation of Bone Mineral Density and Bone Biomarkers in Patients With Type 2 Diabetes Treated With Canagliflozin","volume":"101","author":"Bilezikian","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_303","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/jdi.13340","article-title":"Effects of ipragliflozin versus metformin in combination with sitagliptin on bone and muscle in Japanese patients with type 2 diabetes mellitus: Subanalysis of a prospective, randomized, controlled study (PRIME-V study)","volume":"12","author":"Koshizaka","year":"2021","journal-title":"J. Diabetes Investig."},{"key":"ref_304","unstructured":"U.S. Food & Drug Administration (2021, November 15). FDA Drug Safety Communication: Possible Increased Risk of Fractures of the Hip, Wrist, and Spine with the Use of Proton Pump Inhibitors, Available online: https:\/\/www.fda.gov\/drugs\/postmarket-drug-safety-information-patients-and-providers\/fda-drug-safety-communication-possible-increased-risk-fractures-hip-wrist-and-spine-use-proton-pump#TableofEpidemiologicalStudiesevaluatingfractureriskwithprotonpumpinhibitors."},{"key":"ref_305","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ejphar.2003.09.011","article-title":"Direct effects of proton pump inhibitors on histamine release from rat enterochromaffin-like cells","volume":"481","author":"Yokota","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"ref_306","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1046\/j.1365-2036.1999.00545.x","article-title":"The effects of oral rabeprazole on endocrine and gastric secretory function in healthy volunteers","volume":"13","author":"Dammann","year":"1999","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_307","doi-asserted-by":"crossref","first-page":"211","DOI":"10.7326\/0003-4819-120-3-199402010-00006","article-title":"Omeprazole therapy causes malabsorption of cyanocobalamin (vitamin B12)","volume":"120","author":"Marcuard","year":"1994","journal-title":"Ann. Intern. Med."},{"key":"ref_308","doi-asserted-by":"crossref","unstructured":"Signorelli, S.S., Scuto, S., Marino, E., Giusti, M., Xourafa, A., and Gaudio, A. (2019). Anticoagulants and Osteoporosis. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20215275"},{"key":"ref_309","first-page":"456","article-title":"THU0500|Effects of long-term use of unfractionated heparin (UFH) or low-molecular-weight heparin (LMWH) on bone mineral density (BMD) in patients with nephrotic syndrome","volume":"77","author":"Monov","year":"2018","journal-title":"Ann. Rheum. Dis."},{"key":"ref_310","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/hdi.12854","article-title":"Effect of long-term use of unfractionated or low-molecular-weight heparin on bone mineral density in maintenance hemodialysis patients","volume":"24","author":"Yang","year":"2020","journal-title":"Hemodial. Int."},{"key":"ref_311","doi-asserted-by":"crossref","first-page":"471","DOI":"10.7150\/ijms.39523","article-title":"Association between oral anticoagulants and osteoporosis: Real-world data mining using a multi-methodological approach","volume":"17","author":"Yokoyama","year":"2020","journal-title":"Int. J. Med. Sci."},{"key":"ref_312","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s11657-020-00770-z","article-title":"Trabecular bone score (TBS) and bone mineral density in patients with long-term therapy with warfarin","volume":"15","author":"Marques","year":"2020","journal-title":"Arch. Osteoporos."},{"key":"ref_313","doi-asserted-by":"crossref","first-page":"116000","DOI":"10.1016\/j.bone.2021.116000","article-title":"Bone density and quality in patients treated with direct-acting oral anticoagulants versus warfarin","volume":"150","author":"Nalevaiko","year":"2021","journal-title":"Bone"},{"key":"ref_314","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1097\/QAD.0b013e32801022eb","article-title":"Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: A meta-analytic review","volume":"20","author":"Brown","year":"2006","journal-title":"AIDS"},{"key":"ref_315","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/QAI.0000000000002207","article-title":"Management of osteoporosis in patients living with HIV\u2014A systematic review and meta-analysis","volume":"83","author":"Rosendahl","year":"2020","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"ref_316","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1086\/656412","article-title":"Bone disease in HIV infection: A practical review and recommendations for HIV care providers","volume":"51","author":"McComsey","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"ref_317","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1093\/cid\/cit538","article-title":"Low baseline CD4+ count is associated with greater bone mineral density loss after antiretroviral therapy initiation","volume":"57","author":"Grant","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"ref_318","doi-asserted-by":"crossref","unstructured":"Rochira, V., Zirilli, L., Orlando, G., Santi, D., Brigante, G., Diazzi, C., Carli, F., Carani, C., and Guaraldi, G. (2011). Premature decline of serum total testosterone in HIV-infected men in the HAART-era. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0028512"},{"key":"ref_319","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1002\/jbmr.1988","article-title":"Hepatitis C co-infection and severity of liver disease as risk factors for osteoporotic fractures among HIV-infected patients","volume":"28","author":"Maalouf","year":"2013","journal-title":"J. Bone Miner. Res."},{"key":"ref_320","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s11904-014-0218-8","article-title":"Vitamin D deficiency and altered bone mineral metabolism in HIV-infected individuals","volume":"11","author":"Eckard","year":"2014","journal-title":"Curr. HIV\/AIDS Rep."},{"key":"ref_321","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1002\/jmv.21266","article-title":"HIV-1 triggers apoptosis in primary osteoblasts and HOBIT cells through TNF\u03b1 activation","volume":"80","author":"Gibellini","year":"2008","journal-title":"J. Med. Virol."},{"key":"ref_322","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/jor.22196","article-title":"HIV-1 protein induced modulation of primary human osteoblast differentiation and function via a Wnt\/\u03b2-catenin-dependent mechanism","volume":"31","author":"Butler","year":"2013","journal-title":"J. Orthop. Res."},{"key":"ref_323","doi-asserted-by":"crossref","first-page":"48251","DOI":"10.1074\/jbc.M304676200","article-title":"HIV envelope gp120-mediated regulation of osteoclastogenesis via receptor activator of nuclear factor \u03baB ligand (RANKL) secretion and its modulation by certain HIV protease inhibitors through interferon-\u03b3\/RANKL cross-talk","volume":"278","author":"Fakruddin","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_324","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1089\/aid.2007.0112","article-title":"HIV proteins regulate bone marker secretion and transcription factor activity in cultured human osteoblasts with consequent potential implications for osteoblast function and development","volume":"23","author":"Cotter","year":"2007","journal-title":"AIDS Res. Hum. Retrovir."},{"key":"ref_325","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12977-015-0139-7","article-title":"HIV-1 replicates in human osteoclasts and enhances their differentiation in vitro","volume":"12","author":"Gohda","year":"2015","journal-title":"Retrovirology"},{"key":"ref_326","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1097\/QAD.0000000000000320","article-title":"Is Bone Loss Linked to Chronic Inflammation in Antiretroviral-Na\u00efve HIV-Infected Adults? A 48 Week Matched Cohort Study","volume":"28","author":"Hileman","year":"2014","journal-title":"AIDS"},{"key":"ref_327","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s00774-016-0749-8","article-title":"Bone metabolism dysfunction mediated by the increase of proinflammatory cytokines in chronic HIV infection","volume":"35","author":"Machado","year":"2017","journal-title":"J. Bone Miner. Metab."},{"key":"ref_328","doi-asserted-by":"crossref","unstructured":"Vlot, M.C., Grijsen, M.L., Prins, J.M., de Jongh, R.T., de Jonge, R., den Heijer, M., and Heijboer, A.C. (2018). Effect of antiretroviral therapy on bone turnover and bone mineral density in men with primary HIV-1 infection. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0193679"},{"key":"ref_329","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1086\/656417","article-title":"Comparison of changes in bone density and turnover with abacavir-lamivudine versus tenofovir-emtricitabine in HIV-infected adults: 48-week results from the ASSERT study","volume":"51","author":"Stellbrink","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"ref_330","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/QAD.0000000000001725","article-title":"Switch from tenofovir disoproxil fumarate combination to dolutegravir with rilpivirine improves parameters of bone health","volume":"32","author":"McComsey","year":"2018","journal-title":"AIDS"},{"key":"ref_331","doi-asserted-by":"crossref","first-page":"3368","DOI":"10.1093\/jac\/dku300","article-title":"Improvement in bone mineral density after switching from tenofovir to abacavir in HIV-1-infected patients with low bone mineral density: Two-centre randomized pilot study (OsteoTDF study)","volume":"69","author":"Negredo","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_332","doi-asserted-by":"crossref","first-page":"e655","DOI":"10.1016\/S2352-3018(19)30195-X","article-title":"Bone mineral density in virologically suppressed people aged 60 years or older with HIV-1 switching from a regimen containing tenofovir disoproxil fumarate to an elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide single-tablet regimen: A multicentre, open-label, phase 3b, randomised trial","volume":"6","author":"Maggiolo","year":"2019","journal-title":"Lancet HIV"},{"key":"ref_333","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1007\/s10067-014-2627-x","article-title":"Hypophosphatemic osteomalacia induced by tenofovir in HIV-infected patients","volume":"35","author":"Mateo","year":"2016","journal-title":"Clin. Rheumatol."},{"key":"ref_334","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1097\/00002030-200104130-00005","article-title":"Osteopenia in HIV-infected men: Association with asymptomatic lactic acidemia and lower weight pre-antiretroviral therapy","volume":"15","author":"Carr","year":"2001","journal-title":"AIDS"},{"key":"ref_335","unstructured":"(2021, November 01). EACS (European AIDS Clinical Society) Version 9.0. Available online: http:\/\/www.eacsociety.org\/files\/guidelines_9.0-english.pdf."},{"key":"ref_336","doi-asserted-by":"crossref","first-page":"e5146","DOI":"10.1097\/MD.0000000000005146","article-title":"The efficacy and safety of tenofovir alafenamide versus tenofovir disoproxil fumarate in antiretroviral regimens for HIV-1 therapy: Meta-analysis","volume":"95","author":"Wang","year":"2016","journal-title":"Medicine"},{"key":"ref_337","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S2055-6640(20)30248-X","article-title":"Tenofovir alafenamide versus tenofovir disoproxil fumarate: Is there a true difference in efficacy and safety?","volume":"4","author":"Hill","year":"2018","journal-title":"J. Virus Erad."},{"key":"ref_338","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1093\/cid\/civ010","article-title":"Recommendations for evaluation and management of bone disease in HIV","volume":"60","author":"Brown","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"ref_339","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1007\/s10620-014-3507-6","article-title":"Bone mineral density, bone turnover, and systemic inflammation in non-cirrhotics with chronic hepatitis C","volume":"60","author":"Lai","year":"2015","journal-title":"Dig. Dis. Sci."},{"key":"ref_340","doi-asserted-by":"crossref","unstructured":"Orsini, L.G., Pinheiro, M.M., Castro, C.H., Silva, A.E., and Szejnfeld, V.L. (2013). Bone mineral density measurements, bone markers and serum vitamin D concentrations in men with chronic non-cirrhotic untreated hepatitis C. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0081652"},{"key":"ref_341","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.3748\/wjg.v11.i12.1843","article-title":"Reduced bone mineral density and altered bone turnover markers in patients with non-cirrhotic chronic hepatitis B or C infection","volume":"11","author":"Schiefke","year":"2005","journal-title":"World J. Gastroenterol."},{"key":"ref_342","doi-asserted-by":"crossref","first-page":"e021990","DOI":"10.1136\/bmjopen-2018-021990","article-title":"Association between hepatitis C virus infection and osteoporotic fracture risk among postmenopausal women: A cross-sectional investigation in Taiwan","volume":"9","author":"Lin","year":"2019","journal-title":"BMJ Open"},{"key":"ref_343","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/jmv.21691","article-title":"Virus clearance reduces bone fracture in postmenopausal women with osteoporosis and chronic liver disease caused by hepatitis C virus","volume":"82","author":"Arase","year":"2010","journal-title":"J. Med. Virol."},{"key":"ref_344","doi-asserted-by":"crossref","first-page":"e3943","DOI":"10.1097\/MD.0000000000003943","article-title":"Herpes zoster as a risk factor for osteoporosis: A 15-year nationwide population-based study","volume":"95","author":"Wu","year":"2016","journal-title":"Medicine"},{"key":"ref_345","doi-asserted-by":"crossref","first-page":"4789679","DOI":"10.1155\/2019\/4789679","article-title":"Association between Herpes Zoster and Osteoporosis: A Nested Case-Control Study Using a National Sample Cohort","volume":"2019","author":"Min","year":"2019","journal-title":"BioMed Res. Int."},{"key":"ref_346","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s10096-018-3436-y","article-title":"Herpes zoster and the risks of osteoporosis and fracture: A nationwide cohort study","volume":"38","author":"Lin","year":"2019","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_347","first-page":"97","article-title":"Correlation of serum inflammatory cytokine and immunoglobulin content with post-herpetic neuralgia in patients with acute herpes zoster","volume":"23","author":"Shi","year":"2017","journal-title":"J. Hainan Med. Univ."},{"key":"ref_348","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00223-021-00858-9","article-title":"Diagnosis and Management of Osteoporosis during COVID-19: Systematic Review and Practical Guidance","volume":"109","author":"Hampson","year":"2021","journal-title":"Calcif. Tissue Int."},{"key":"ref_349","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"ref_350","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/s41574-020-0379-z","article-title":"Managing fragility fractures during the COVID-19 pandemic","volume":"16","author":"Napoli","year":"2020","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_351","doi-asserted-by":"crossref","first-page":"115041","DOI":"10.1016\/j.bone.2019.115041","article-title":"The angiotensin converting enzyme 2\/angiotensin-(1-7)\/Mas Receptor axis as a key player in alveolar bone remodeling","volume":"128","author":"Santos","year":"2019","journal-title":"Bone"},{"key":"ref_352","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1093\/cid\/ciz077","article-title":"Increased fragility fracture rates in older men with osteomyelitis","volume":"69","author":"Hsieh","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"ref_353","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1172\/JCI46262","article-title":"Osteoimmunology at the nexus of arthritis, osteoporosis, cancer, and infection","volume":"121","author":"Jones","year":"2011","journal-title":"J. Clin. Investig."},{"key":"ref_354","doi-asserted-by":"crossref","unstructured":"Claro, T., Widaa, A., O\u2019Seaghdha, M., Miajlovic, H., Foster, T.J., O\u2019Brien, F.J., and Kerrigan, S.W. (2011). Staphylococcus aureus protein A binds to osteoblasts and triggers signals that weaken bone in osteomyelitis. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0018748"},{"key":"ref_355","doi-asserted-by":"crossref","first-page":"13127","DOI":"10.1038\/s41598-017-12419-y","article-title":"Risk of sarcopenia and osteoporosis in male tuberculosis survivors: Korea National Health and Nutrition Examination Survey","volume":"7","author":"Choi","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_356","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/ije\/dym247","article-title":"Low serum vitamin D levels and tuberculosis: A systematic review and meta-analysis","volume":"37","author":"Nnoaham","year":"2008","journal-title":"Int. J. Epidemiol."},{"key":"ref_357","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.coi.2013.05.005","article-title":"Inflammation in tuberculosis: Interactions, imbalances and interventions","volume":"25","author":"Kaufmann","year":"2013","journal-title":"Curr. Opin. Immunol."},{"key":"ref_358","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/eji.200838693","article-title":"Pattern and diversity of cytokine production differentiates between Mycobacterium tuberculosis infection and disease","volume":"39","author":"Sutherland","year":"2009","journal-title":"Eur. J. Immunol."},{"key":"ref_359","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.bone.2018.02.019","article-title":"Bone and blood interactions in human health and disease","volume":"119","author":"Wu","year":"2019","journal-title":"Bone"},{"key":"ref_360","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1359\/jbmr.040113","article-title":"Osteoprotegerin and RANKL in the pathogenesis of thalassemia-induced osteoporosis: New pieces of the puzzle","volume":"19","author":"Morabito","year":"2004","journal-title":"J. Bone Miner. Res."},{"key":"ref_361","first-page":"4615","article-title":"Human myeloma cells stimulate the receptor activator of nuclear factor-\u03baB ligand (RANKL) in T lymphocytes: A potential role in multiple myeloma bone disease","volume":"100","author":"Giuliani","year":"2002","journal-title":"Blood J. Am. Soc. Hematol."},{"key":"ref_362","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1080\/17474086.2019.1640115","article-title":"Monoclonal antibodies against RANKL and sclerostin for myeloma-related bone disease: Can they change the standard of care?","volume":"12","author":"Kleber","year":"2019","journal-title":"Expert Rev. Hematol."},{"key":"ref_363","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/s00223-015-9969-5","article-title":"Dickkopf-1 and sclerostin serum levels in patients with systemic mastocytosis","volume":"96","author":"Rossini","year":"2015","journal-title":"Calcif. Tissue Int."},{"key":"ref_364","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ejim.2011.11.009","article-title":"Anemia as a risk factor for low bone mineral density in postmenopausal Turkish women","volume":"23","author":"Korkmaz","year":"2012","journal-title":"Eur. J. Intern. Med."},{"key":"ref_365","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1210\/jc.2017-00266","article-title":"Older men with anemia have increased fracture risk independent of bone mineral density","volume":"102","author":"Lee","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_366","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.3390\/nu7042324","article-title":"Chronic iron deficiency as an emerging risk factor for osteoporosis: A hypothesis","volume":"7","author":"Toxqui","year":"2015","journal-title":"Nutrients"},{"key":"ref_367","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1007\/s003300050926","article-title":"Imaging features of thalassemia","volume":"9","author":"Engin","year":"1999","journal-title":"Eur. Radiol."},{"key":"ref_368","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1365-2265.2008.03191.x","article-title":"Bone demineralization in adult thalassaemic patients: Contribution of GH and IGF-I at different skeletal sites","volume":"69","author":"Scacchi","year":"2008","journal-title":"Clin. Endocrinol."},{"key":"ref_369","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0026-0495(98)90237-2","article-title":"Bone mineral density in prepubertal children with \u03b2-thalassemia: Correlation with growth and hormonal data","volume":"47","author":"Soliman","year":"1998","journal-title":"Metabolism"},{"key":"ref_370","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/BF01352012","article-title":"Iron distribution in thalassemic bone by energy-loss spectroscopy and electron spectroscopic imaging","volume":"53","author":"Bordat","year":"1993","journal-title":"Calcif. Tissue Int."},{"key":"ref_371","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1136\/adc.62.5.474","article-title":"Serum 1, 25 dihydroxyvitamin D and osteocalcin concentrations in thalassaemia major","volume":"62","author":"Dandona","year":"1987","journal-title":"Arch. Dis. Child."},{"key":"ref_372","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1007\/s00247-002-0664-0","article-title":"Patterns of bone diseases in transfusion-dependent homozygous thalassaemia major: Predominance of osteoporosis and desferrioxamine-induced bone dysplasia","volume":"32","author":"Chan","year":"2002","journal-title":"Pediatr. Radiol."},{"key":"ref_373","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1016\/j.bone.2007.02.020","article-title":"The \u201clively\u201d cytokines network in \u03b2-thalassemia major-related osteoporosis","volume":"40","author":"Morabito","year":"2007","journal-title":"Bone"},{"key":"ref_374","first-page":"1193","article-title":"Zoledronic acid for the treatment of osteoporosis in patients with beta-thalassemia: Results from a single-center, randomized, placebo-controlled trial","volume":"91","author":"Voskaridou","year":"2006","journal-title":"Haematologica"},{"key":"ref_375","doi-asserted-by":"crossref","unstructured":"Gaudio, A., Xourafa, A., Rapisarda, R., Zanoli, L., Signorelli, S.S., and Castellino, P. (2020). Hematological diseases and osteoporosis. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21103538"},{"key":"ref_376","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1111\/trf.13237","article-title":"Effects of teriparatide retreatment in a patient with \u03b2-thalassemia major","volume":"55","author":"Tournis","year":"2015","journal-title":"Transfusion"},{"key":"ref_377","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1182\/bloodadvances.2018023085","article-title":"Denosumab in transfusion-dependent thalassemia osteoporosis: A randomized, placebo-controlled, double-blind phase 2b clinical trial","volume":"2","author":"Voskaridou","year":"2018","journal-title":"Blood Adv."},{"key":"ref_378","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1160\/TH11-08-05563","article-title":"Reduced bone mineral density in patients with haemophilia A and B in Northern Greece","volume":"107","author":"Anagnostis","year":"2012","journal-title":"Thromb. Haemost."},{"key":"ref_379","doi-asserted-by":"crossref","first-page":"e870","DOI":"10.1111\/j.1365-2516.2011.02514.x","article-title":"Role of exercise and physical activity on haemophilic arthropathy, fall prevention and osteoporosis","volume":"17","author":"Forsyth","year":"2011","journal-title":"Haemophilia"},{"key":"ref_380","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1365-2516.2006.01405.x","article-title":"Osteoporosis in haemophilia\u2013an underestimated comorbidity?","volume":"13","author":"Wallny","year":"2007","journal-title":"Haemophilia"},{"key":"ref_381","doi-asserted-by":"crossref","unstructured":"Simpson, M.L., and Valentino, L.A. (2013). Vitamin D deficiency and Osteoporosis in Hemophilia: An Underappreciated Risk, American Society of Hematology.","DOI":"10.1182\/blood.V122.21.3593.3593"},{"key":"ref_382","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/hae.13384","article-title":"The role of sclerostin\/dickkopf-1 and receptor activator of nuclear factor kB ligand\/osteoprotegerin signalling pathways in the development of osteoporosis in patients with haemophilia A and B: A cross-sectional study","volume":"24","author":"Anagnostis","year":"2018","journal-title":"Haemophilia"},{"key":"ref_383","doi-asserted-by":"crossref","first-page":"31704","DOI":"10.1074\/jbc.M109.030312","article-title":"Factor VIII-von Willebrand factor complex inhibits osteoclastogenesis and controls cell survival","volume":"284","author":"Duplomb","year":"2009","journal-title":"J. Biol. Chem."},{"key":"ref_384","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/hae.12240","article-title":"Bone density in haemophilia: A single institutional cross-sectional study","volume":"20","author":"Kempton","year":"2014","journal-title":"Haemophilia"},{"key":"ref_385","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1365-2516.2008.01912.x","article-title":"Long-term prophylaxis in severe haemophilia seems to preserve bone mineral density","volume":"15","author":"Khawaji","year":"2009","journal-title":"Haemophilia"},{"key":"ref_386","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1359\/jbmr.0301212","article-title":"Fracture risk in monoclonal gammopathy of undetermined significance","volume":"19","author":"Melton","year":"2004","journal-title":"J. Bone Miner. Res."},{"key":"ref_387","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1359\/JBMR.041131","article-title":"Fracture risk with multiple myeloma: A population-based study","volume":"20","author":"Melton","year":"2005","journal-title":"J. Bone Miner. Res."},{"key":"ref_388","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/j.1600-0609.2008.01065.x","article-title":"Serum concentrations of DKK-1 correlate with the extent of bone disease in patients with multiple myeloma","volume":"80","author":"Kaiser","year":"2008","journal-title":"Eur. J. Haematol."},{"key":"ref_389","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.1182\/blood-2004-12-4940","article-title":"Myeloma cells suppress bone formation by secreting a soluble Wnt inhibitor, sFRP-2","volume":"106","author":"Oshima","year":"2005","journal-title":"Blood"},{"key":"ref_390","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1365-2141.2010.08207.x","article-title":"Monoclonal gammopathy of undetermined significance: A consensus statement","volume":"150","author":"Berenson","year":"2010","journal-title":"Br. J. Haematol."},{"key":"ref_391","doi-asserted-by":"crossref","first-page":"984","DOI":"10.3324\/haematol.2013.100552","article-title":"The clinical relevance and management of monoclonal gammopathy of undetermined significance and related disorders: Recommendations from the European Myeloma Network","volume":"99","author":"Palumbo","year":"2014","journal-title":"Haematologica"},{"key":"ref_392","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1359\/jbmr.1999.14.12.2048","article-title":"Zoledronate is a potent inhibitor of myeloma cell growth and secretion of IL-6 and MMP-1 by the tumoral environment","volume":"14","author":"Derenne","year":"1999","journal-title":"J. Bone Miner. Res."},{"key":"ref_393","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.bone.2010.08.008","article-title":"Novel actions of bisphosphonates in bone: Preservation of osteoblast and osteocyte viability","volume":"49","author":"Bellido","year":"2011","journal-title":"Bone"},{"key":"ref_394","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1634\/theoncologist.10-90001-3","article-title":"Preclinical perspectives on bisphosphonate renal safety","volume":"10","author":"Body","year":"2005","journal-title":"Oncologist"},{"key":"ref_395","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1002\/jbmr.1613","article-title":"A single-dose study of denosumab in patients with various degrees of renal impairment","volume":"27","author":"Block","year":"2012","journal-title":"J. Bone Miner. Res."},{"key":"ref_396","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1038\/sj.leu.2404806","article-title":"Bortezomib inhibits human osteoclastogenesis","volume":"21","author":"Krebbel","year":"2007","journal-title":"Leukemia"},{"key":"ref_397","first-page":"371","article-title":"Anti-DKK1 mAb (BHQ880) as a potential therapeutic agent for multiple myeloma","volume":"114","author":"Fulciniti","year":"2009","journal-title":"Blood J. Am. Soc. Hematol."},{"key":"ref_398","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1038\/leu.2017.152","article-title":"Genetic deletion of Sost or pharmacological inhibition of sclerostin prevent multiple myeloma-induced bone disease without affecting tumor growth","volume":"31","author":"Anderson","year":"2017","journal-title":"Leukemia"},{"key":"ref_399","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1398-9995.2011.02780.x","article-title":"High prevalence of fractures and osteoporosis in patients with indolent systemic mastocytosis","volume":"67","year":"2012","journal-title":"Allergy"},{"key":"ref_400","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.bone.2017.09.005","article-title":"Prevalence and risk factors for fragility fracture in systemic mastocytosis","volume":"105","author":"Eischen","year":"2017","journal-title":"Bone"},{"key":"ref_401","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.jaci.2009.05.003","article-title":"Prognosis in adult indolent systemic mastocytosis: A long-term study of the Spanish Network on Mastocytosis in a series of 145 patients","volume":"124","author":"Escribano","year":"2009","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_402","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.jaci.2013.06.019","article-title":"Serum levels of bone cytokines are increased in indolent systemic mastocytosis associated with osteopenia or osteoporosis","volume":"132","author":"Rabenhorst","year":"2013","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_403","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.iac.2014.01.011","article-title":"Bone involvement and osteoporosis in mastocytosis","volume":"34","author":"Rossini","year":"2014","journal-title":"Immunol. Allergy Clin. N. Am."},{"key":"ref_404","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1136\/ard.2009.124511","article-title":"Systemic mastocytosis and bone involvement in a cohort of 75 patients","volume":"69","author":"Barete","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"ref_405","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s00223-017-0241-z","article-title":"Denosumab for the treatment of mastocytosis-related osteoporosis: A case series","volume":"100","author":"Orsolini","year":"2017","journal-title":"Calcif. Tissue Int."},{"key":"ref_406","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.amjmed.2011.02.038","article-title":"Interferon alpha and pamidronate in osteoporosis with fracture secondary to mastocytosis","volume":"124","author":"Laroche","year":"2011","journal-title":"Am. J. Med."},{"key":"ref_407","first-page":"144","article-title":"Teriparatide may accelerate the growth of a pre-existing malignant tumor in an elderly patient with osteoporosis: A case report","volume":"12","author":"Ogawa","year":"2020","journal-title":"Mol. Clin. Oncol."},{"key":"ref_408","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13046-018-1001-2","article-title":"RANKL\/RANK\/OPG system beyond bone remodeling: Involvement in breast cancer and clinical perspectives","volume":"38","author":"Infante","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_409","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1080\/10428190701471973","article-title":"Elderly patients with non-Hodgkin lymphoma who receive chemotherapy are at higher risk for osteoporosis and fractures","volume":"48","author":"Cabanillas","year":"2007","journal-title":"Leuk. Lymphoma"},{"key":"ref_410","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00198-018-4758-4","article-title":"Hormone therapy and osteoporosis in breast cancer survivors: Assessment of risk and adherence to screening recommendations","volume":"30","author":"Hamood","year":"2019","journal-title":"Osteoporos. Int."},{"key":"ref_411","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/bjc.1990.58","article-title":"Bone mineral density after adjuvant chemotherapy for premenopausal breast cancer","volume":"61","author":"Bruning","year":"1990","journal-title":"Br. J. Cancer"},{"key":"ref_412","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1359\/jbmr.060508","article-title":"Effect of an aromatase inhibitor on BMD and bone turnover markers: 2-year results of the Anastrozole, Tamoxifen, Alone or in Combination (ATAC) trial (18233230)","volume":"21","author":"Eastell","year":"2006","journal-title":"J. Bone Miner. Res."},{"key":"ref_413","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1056\/NEJMoa010845","article-title":"Pamidronate to prevent bone loss during androgen-deprivation therapy for prostate cancer","volume":"345","author":"Smith","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"ref_414","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1177\/1078155208091866","article-title":"Screening and management of osteoporosis in breast cancer patients on aromatase inhibitors","volume":"14","author":"Gibson","year":"2008","journal-title":"J. Oncol. Pharm. Pract."},{"key":"ref_415","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jocd.2009.05.001","article-title":"Implementation of osteoporosis screening guidelines in prostate cancer patients on androgen ablation","volume":"12","author":"Duncan","year":"2009","journal-title":"J. Clin. Densitom."},{"key":"ref_416","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1093\/annonc\/mdn164","article-title":"Practical guidance for the management of aromatase inhibitor-associated bone loss","volume":"19","author":"Hadji","year":"2008","journal-title":"Ann. Oncol."},{"key":"ref_417","doi-asserted-by":"crossref","first-page":"657","DOI":"10.3389\/fimmu.2018.00657","article-title":"Immunoporosis: Immunology of Osteoporosis-Role of T Cells","volume":"9","author":"Srivastava","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_418","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1084\/jem.20061775","article-title":"Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction","volume":"203","author":"Sato","year":"2006","journal-title":"J. Exp. Med."},{"key":"ref_419","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1002\/jbmr.3143","article-title":"BPS804 Anti-Sclerostin Antibody in Adults With Moderate Osteogenesis Imperfecta: Results of a Randomized Phase 2a Trial","volume":"32","author":"Glorieux","year":"2017","journal-title":"J. Bone Miner. Res."},{"key":"ref_420","doi-asserted-by":"crossref","first-page":"613720","DOI":"10.3389\/fmed.2020.613720","article-title":"Osteoporosis in Inflammatory Arthritides: New Perspective on Pathogenesis and Treatment","volume":"7","author":"Rotta","year":"2020","journal-title":"Front. Med."},{"key":"ref_421","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/1529-0131(200003)43:3<522::AID-ANR7>3.0.CO;2-Y","article-title":"Bone mineral density and frequency of osteoporosis in female patients with rheumatoid arthritis: Results from 394 patients in the Oslo County Rheumatoid Arthritis register","volume":"43","author":"Haugeberg","year":"2000","journal-title":"Arthritis Rheum."},{"key":"ref_422","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1093\/rheumatology\/keu162","article-title":"Prevalence and clinical prediction of osteoporosis in a contemporary cohort of patients with rheumatoid arthritis","volume":"53","author":"Hauser","year":"2014","journal-title":"Rheumatology"},{"key":"ref_423","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1007\/s00198-018-4473-1","article-title":"Incidence of fractures among patients with rheumatoid arthritis: A systematic review and meta-analysis","volume":"29","author":"Jin","year":"2018","journal-title":"Osteoporos. Int."},{"key":"ref_424","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s11926-019-0836-7","article-title":"Osteoporosis Pathophysiology, Epidemiology, and Screening in Rheumatoid Arthritis","volume":"21","author":"Adami","year":"2019","journal-title":"Curr. Rheumatol. Rep."},{"key":"ref_425","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/art.27252","article-title":"Periarticular bone structure in rheumatoid arthritis patients and healthy individuals assessed by high-resolution computed tomography","volume":"62","author":"Stach","year":"2010","journal-title":"Arthritis Rheum."},{"key":"ref_426","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3389\/fimmu.2018.00095","article-title":"Senescent T-Cells Promote Bone Loss in Rheumatoid Arthritis","volume":"9","author":"Fessler","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_427","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s13075-017-1362-5","article-title":"Anti-citrullinated protein antibodies and bone loss in patients with early arthritis: Comment on the article \u201cAnti-citrullinated protein antibodies and high levels of rheumatoid factor are associated with systemic bone loss in patients with early untreated rheumatoid arthritis\u201d by Bugatti et al","volume":"19","author":"Llorente","year":"2017","journal-title":"Arthritis Res. Ther."},{"key":"ref_428","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1007\/s00296-017-3674-9","article-title":"Anti-citrullinated protein antibodies are associated with decreased bone mineral density: Baseline data from a register of early arthritis patients","volume":"37","author":"Llorente","year":"2017","journal-title":"Rheumatol. Int."},{"key":"ref_429","doi-asserted-by":"crossref","unstructured":"Regueiro, C., Ortiz, A.M., Boveda, M.D., Casta\u00f1eda, S., Gonzalez-Alvaro, I., and Gonzalez, A. (2018). Association of high titers of anti-carbamylated protein antibodies with decreased bone mineral density in early arthritis patients. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0202583"},{"key":"ref_430","doi-asserted-by":"crossref","first-page":"104354","DOI":"10.1016\/j.phrs.2019.104354","article-title":"Effects of biological and targeted synthetic DMARDs on bone loss in rheumatoid arthritis","volume":"147","author":"Orsolini","year":"2019","journal-title":"Pharmacol. Res."},{"key":"ref_431","first-page":"813","article-title":"Conventional synthetic disease-modifying antirheumatic drugs and bone mineral density in rheumatoid arthritis patients with osteoporosis: Possible beneficial effect of leflunomide","volume":"37","author":"Kwon","year":"2019","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_432","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.intimp.2018.12.050","article-title":"Inhibition of tumor necrosis factor-alpha (TNF-alpha) in patients with early rheumatoid arthritis results in acute changes of bone modulators","volume":"67","author":"Fassio","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"ref_433","doi-asserted-by":"crossref","unstructured":"Chen, Y.M., Chen, H.H., Huang, W.N., Liao, T.L., Chen, J.P., Chao, W.C., Lin, C.T., Hung, W.T., Hsieh, C.W., and Hsieh, T.Y. (2017). Tocilizumab potentially prevents bone loss in patients with anticitrullinated protein antibody-positive rheumatoid arthritis. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0188454"},{"key":"ref_434","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s00296-017-3922-z","article-title":"Abatacept might increase bone mineral density at femoral neck for patients with rheumatoid arthritis in clinical practice: AIRTIGHT study","volume":"38","author":"Tada","year":"2018","journal-title":"Rheumatol. Int."},{"key":"ref_435","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00296-003-0298-z","article-title":"The effect of low-dose methotrexate on bone mineral density in patients with early rheumatoid arthritis","volume":"23","author":"Tascioglu","year":"2003","journal-title":"Rheumatol. Int."},{"key":"ref_436","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1136\/annrheumdis-2020-217892","article-title":"Systemic evaluation of the relationship between psoriasis, psoriatic arthritis and osteoporosis: Observational and Mendelian randomisation study","volume":"79","author":"Xia","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"ref_437","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.jaad.2016.11.046","article-title":"Association of psoriasis and psoriatic arthritis with osteoporosis and pathological fractures","volume":"76","author":"Kathuria","year":"2017","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_438","doi-asserted-by":"crossref","first-page":"e000631","DOI":"10.1136\/rmdopen-2017-000631","article-title":"Osteoporosis in psoriatic arthritis: A cross-sectional study of an outpatient clinic population","volume":"4","author":"Gulati","year":"2018","journal-title":"RMD Open"},{"key":"ref_439","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s00223-017-0380-2","article-title":"Altered Bone Remodeling in Psoriatic Disease: New Insights and Future Directions","volume":"102","author":"Paine","year":"2018","journal-title":"Calcif. Tissue Int."},{"key":"ref_440","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1007\/s10067-012-2018-0","article-title":"High prevalence of low bone mineral density in patients within 10 years of onset of ankylosing spondylitis: A systematic review","volume":"31","author":"Claushuis","year":"2012","journal-title":"Clin. Rheumatol."},{"key":"ref_441","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1002\/jbmr.2217","article-title":"Ankylosing spondylitis is associated with an increased risk of vertebral and nonvertebral clinical fractures: A population-based cohort study","volume":"29","author":"Vestergaard","year":"2014","journal-title":"J. Bone Miner. Res."},{"key":"ref_442","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1002\/jbmr.3684","article-title":"Long-Term Treatment With TNF-Alpha Inhibitors Improves Bone Mineral Density But Not Vertebral Fracture Progression in Ankylosing Spondylitis","volume":"34","author":"Beek","year":"2019","journal-title":"J. Bone Miner. Res."},{"key":"ref_443","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11657-019-0667-1","article-title":"A meta-analysis of secondary osteoporosis in systemic lupus erythematosus: Prevalence and risk factors","volume":"15","author":"Gu","year":"2019","journal-title":"Arch. Osteoporos."},{"key":"ref_444","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1177\/0961203318768886","article-title":"Predictors of fracture risk in patients with systemic lupus erythematosus","volume":"27","author":"Dey","year":"2018","journal-title":"Lupus"},{"key":"ref_445","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1177\/0961203317709953","article-title":"Osteoporotic fractures in patients with systemic lupus erythematosus and end stage renal disease","volume":"27","author":"Le","year":"2018","journal-title":"Lupus"},{"key":"ref_446","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/BOR.0000000000000290","article-title":"Lupus and fractures","volume":"28","author":"Bultink","year":"2016","journal-title":"Curr. Opin. Rheumatol."},{"key":"ref_447","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1177\/0961203318815593","article-title":"Bone turnover markers in relation to vitamin D status and disease activity in adults with systemic lupus erythematosus","volume":"28","author":"Sarkissian","year":"2019","journal-title":"Lupus"},{"key":"ref_448","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.1007\/s00198-017-4189-7","article-title":"Inflammatory diseases and bone fragility","volume":"28","author":"Briot","year":"2017","journal-title":"Osteoporos. Int."},{"key":"ref_449","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1002\/jbmr.3523","article-title":"Glucocorticoid Exposure and Fracture Risk in a Cohort of US Patients With Selected Conditions","volume":"33","author":"Balasubramanian","year":"2018","journal-title":"J. Bone Miner. Res."},{"key":"ref_450","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s00198-014-2860-9","article-title":"Lower P1NP serum levels: A predictive marker of bone loss after 1 year follow-up in premenopausal systemic lupus erythematosus patients","volume":"26","author":"Seguro","year":"2015","journal-title":"Osteoporos. Int."},{"key":"ref_451","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1179\/2295333715Y.0000000002","article-title":"Prevalence and risk factors of low bone mineral density in patients with multiple sclerosis","volume":"70","author":"Basaran","year":"2015","journal-title":"Acta Clin. Belg."},{"key":"ref_452","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1212\/CPJ.0000000000000669","article-title":"Multiple sclerosis is associated with low bone mineral density and osteoporosis","volume":"9","author":"Bisson","year":"2019","journal-title":"Neurol. Clin. Pract."},{"key":"ref_453","doi-asserted-by":"crossref","first-page":"904","DOI":"10.3109\/00207454.2014.988332","article-title":"BMI levels with MS Bone mineral density levels in adults with multiple sclerosis: A meta-analysis","volume":"125","author":"Huang","year":"2015","journal-title":"Int. J. Neurosci."},{"key":"ref_454","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.msard.2016.02.003","article-title":"Bone health in patients with multiple sclerosis relapses","volume":"6","author":"Murphy","year":"2016","journal-title":"Mult. Scler. Relat. Disord."},{"key":"ref_455","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jneuroim.2011.12.004","article-title":"Increased levels of IL-23 and osteopontin in serum and cerebrospinal fluid of multiple sclerosis patients","volume":"244","author":"Wen","year":"2012","journal-title":"J. Neuroimmunol."},{"key":"ref_456","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.jocd.2017.06.022","article-title":"FRAX update","volume":"20","author":"Kanis","year":"2017","journal-title":"J. Clin. Densitom."},{"key":"ref_457","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1007\/s00198-012-1940-y","article-title":"The effects of smoking on bone metabolism","volume":"23","author":"Yoon","year":"2012","journal-title":"Osteoporos. Int."},{"key":"ref_458","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s198-002-8342-9","article-title":"Relationships between intestinal calcium absorption, serum vitamin D metabolites and smoking in postmenopausal women","volume":"13","author":"Need","year":"2002","journal-title":"Osteoporos. Int."},{"key":"ref_459","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1530\/eje.1.01816","article-title":"Serum parathyroid hormone (PTH) levels in smokers and non-smokers. The fifth Troms\u00f8 study","volume":"152","author":"Jorde","year":"2005","journal-title":"Eur. J. Endocrinol."},{"key":"ref_460","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s40429-013-0003-6","article-title":"Women and smoking: The effect of gender on the epidemiology, health effects, and cessation of smoking","volume":"1","author":"Allen","year":"2014","journal-title":"Curr. Addict. Rep."},{"key":"ref_461","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1089\/jwh.2006.15.1141","article-title":"Impact of smoking cessation on bone mineral density in postmenopausal women","volume":"15","author":"Oncken","year":"2006","journal-title":"J. Women\u2019s Health"},{"key":"ref_462","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00198-015-3290-z","article-title":"Smoking, smoking cessation, and fracture risk in elderly women followed for 10 years","volume":"27","author":"Thorin","year":"2016","journal-title":"Osteoporos. Int."},{"key":"ref_463","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1007\/s00223-021-00836-1","article-title":"Disuse Osteoporosis: Clinical and Mechanistic Insights","volume":"110","author":"Rolvien","year":"2021","journal-title":"Calcif. Tissue Int."},{"key":"ref_464","doi-asserted-by":"crossref","first-page":"e10375","DOI":"10.1002\/jbm4.10375","article-title":"Administration of Denosumab Preserves Bone Mineral Density at the Knee in Persons With Subacute Spinal Cord Injury: Findings From a Randomized Clinical Trial","volume":"4","author":"Cirnigliaro","year":"2020","journal-title":"JBMR Plus"},{"key":"ref_465","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1002\/jbmr.2549","article-title":"Sclerostin Antibody Preserves the Morphology and Structure of Osteocytes and Blocks the Severe Skeletal Deterioration After Motor-Complete Spinal Cord Injury in Rats","volume":"30","author":"Qin","year":"2015","journal-title":"J. Bone Miner. Res."},{"key":"ref_466","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1111\/bcp.13803","article-title":"Genetic approaches to metabolic bone diseases","volume":"85","author":"Hannan","year":"2019","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_467","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/S0140-6736(15)00728-X","article-title":"Osteogenesis imperfecta","volume":"387","author":"Forlino","year":"2016","journal-title":"Lancet"},{"key":"ref_468","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/jbmr.2604","article-title":"Two Rare Mutations in the COL1A2 Gene Associate With Low Bone Mineral Density and Fractures in Iceland","volume":"31","author":"Styrkarsdottir","year":"2016","journal-title":"J. Bone Miner. Res."},{"key":"ref_469","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1302\/1863-2548.13.180190","article-title":"Current concepts in osteogenesis imperfecta: Bone structure, biomechanics and medical management","volume":"13","author":"Nijhuis","year":"2019","journal-title":"J. Child. Orthop."},{"key":"ref_470","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.bone.2013.11.023","article-title":"Mineral particle size in children with osteogenesis imperfecta type I is not increased independently of specific collagen mutations","volume":"60","author":"Schmidt","year":"2014","journal-title":"Bone"},{"key":"ref_471","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1007\/s00198-015-3156-4","article-title":"Bone structure assessed by HR-pQCT, TBS and DXL in adult patients with different types of osteogenesis imperfecta","volume":"26","author":"Kocijan","year":"2015","journal-title":"Osteoporos. Int."},{"key":"ref_472","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.bone.2014.09.003","article-title":"Increased intra-cortical porosity reduces bone stiffness and strength in pediatric patients with osteogenesis imperfecta","volume":"69","author":"Vardakastani","year":"2014","journal-title":"Bone"},{"key":"ref_473","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.bone.2014.05.022","article-title":"Reduced diaphyseal strength associated with high intracortical vascular porosity within long bones of children with osteogenesis imperfecta","volume":"66","author":"Albert","year":"2014","journal-title":"Bone"},{"key":"ref_474","first-page":"Cd005088","article-title":"Bisphosphonate therapy for osteogenesis imperfecta","volume":"10","author":"Dwan","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_475","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/apa.14154","article-title":"Systematic review of the effect of denosumab on children with osteogenesis imperfecta showed inconsistent findings","volume":"107","author":"Li","year":"2018","journal-title":"Acta Paediatr."},{"key":"ref_476","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nature14878","article-title":"Whole-genome sequencing identifies EN1 as a determinant of bone density and fracture","volume":"526","author":"Zheng","year":"2015","journal-title":"Nature"},{"key":"ref_477","doi-asserted-by":"crossref","unstructured":"Younes, N., Syed, N., Yadav, S.K., Haris, M., Abdallah, A.M., and Abu-Madi, M. (2021). A Whole-Genome Sequencing Association Study of Low Bone Mineral Density Identifies New Susceptibility Loci in the Phase I Qatar Biobank Cohort. J. Pers. Med., 11.","DOI":"10.29117\/quarfe.2021.0115"},{"key":"ref_478","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00198-012-2074-y","article-title":"European guidance for the diagnosis and management of osteoporosis in postmenopausal women","volume":"24","author":"Kanis","year":"2013","journal-title":"Osteoporos. Int."},{"key":"ref_479","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1016\/j.injury.2017.08.036","article-title":"Surgical treatment of osteoporotic fractures: An update on the principles of management","volume":"48","author":"Yaacobi","year":"2017","journal-title":"Injury"},{"key":"ref_480","doi-asserted-by":"crossref","unstructured":"Ammarullah, M.I., Afif, I.Y., Maula, M.I., Winarni, T.I., Tauviqirrahman, M., Akbar, I., Basri, H., van der Heide, E., and Jamari, J.J.M. (2021). Tresca Stress Simulation of Metal-on-Metal Total Hip Arthroplasty during Normal Walking Activity. Materials, 14.","DOI":"10.3390\/ma14247554"},{"key":"ref_481","doi-asserted-by":"crossref","unstructured":"Jamari, J., Ammarullah, M.I., Saad, A.P.M., Syahrom, A., Uddin, M., van der Heide, E., and Basri, H. (2021). The effect of bottom profile dimples on the femoral head on wear in metal-on-metal total hip arthroplasty. J. Funct. Biomater., 12.","DOI":"10.3390\/jfb12020038"},{"key":"ref_482","doi-asserted-by":"crossref","first-page":"101117","DOI":"10.1016\/j.bonr.2021.101117","article-title":"The effect of osteoporosis and its treatment on fracture healing a systematic review of animal and clinical studies","volume":"15","author":"Gorter","year":"2021","journal-title":"Bone Rep."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/11\/9\/2382\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:59:43Z","timestamp":1760137183000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/11\/9\/2382"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,24]]},"references-count":482,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2022,5]]}},"alternative-id":["jcm11092382"],"URL":"https:\/\/doi.org\/10.3390\/jcm11092382","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,24]]}}}